Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3048821	pt-dxm-r1	— (—)	4830	5924	100.00%	Distribution not available
3048821	pt-dxm-r1	nmol/l (nmol/l)	76	76	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity and other hyperalimentation

1184

2959

3.85

307.65

1.2

25.60

37.70

nmol/l

1.11

Obesity

1182

2954

3.86

307.65

1.2

25.60

37.70

nmol/l

1.11

Other nutritional deficiencies

1234

3020

3.82

307.65

1.2

28.41

36.52

nmol/l

0.59

Obesity due to excess calories

920

2267

4.17

307.65

1.2

25.75

32.00

nmol/l

0.74

Disorders of other endocrine glands

939

1992

4.78

307.65

1.3

1.2

26.60

32.12

nmol/l

0.50

Hypertension, essential

1101

1676

3.78

289.55

1.2

28.00

31.55

nmol/l

0.26

Endocrine, nutritional and metabolic diseases

965

1151

4.29

284.22

1.2

30.65

33.77

nmol/l

0.23

Exclusions for E4_PCOS_BROAD

464

742

6.56

277.71

1.5

1.2

26.14

37.06

nmol/l

—

Hypertensive diseases (excluding secondary)

819

1066

4.56

274.20

1.2

27.12

31.41

nmol/l

0.33

Hypertension

1080

1719

3.60

266.16

1.2

27.13

30.90

nmol/l

0.29

Hypertensive diseases

1080

1722

3.59

265.59

1.2

27.13

30.59

nmol/l

0.27

Obesity, other/unspecified

671

1551

4.45

264.04

1.2

22.40

35.81

nmol/l

—

Sleep apnoea, including avohilmo

1340

2962

2.77

223.74

1.2

29.06

33.72

nmol/l

0.39

Sleep apnoea

1286

2941

2.79

220.60

1.2

30.94

33.43

nmol/l

0.16

Type 2 diabetes

1287

2768

2.73

205.75

1.2

24.55

35.20

nmol/l

1.75

Osteopathies and chondropathies

852

2491

3.18

202.38

1.2

43.14

31.90

nmol/l

—

Diabetes mellitus

1313

2871

2.67

202.37

1.2

24.55

38.41

nmol/l

1.46

Diabetes, varying definitions

1300

2877

2.65

197.57

1.2

24.55

38.41

nmol/l

1.46

Benign neoplasms

1129

2185

2.84

191.25

1.3

1.2

28.47

30.86

nmol/l

0.19

Type 2 diabetes, wide definition

1014

2215

2.93

189.00

1.3

1.2

26.83

39.08

nmol/l

—

Hypothyroidism (congenital or acquired)

343

243

8.04

187.94

1.2

31.27

35.90

nmol/l

—

Diabetes medication

1312

3042

2.55

185.08

1.2

25.05

38.43

nmol/l

1.37

Type 2 diabetes, definitions combined

1203

2661

2.66

184.54

1.2

23.89

37.13

nmol/l

2.08

Type 2 diabetes, strict (exclude DM1)

1207

2676

2.66

184.36

1.2

23.89

37.13

nmol/l

2.08

Other (not insulin) diabetes medications

1250

2853

2.60

184.02

1.2

24.35

37.13

nmol/l

2.05

Hypothyroidism, levothyroxine purchases

335

243

7.86

180.77

1.2

31.27

35.90

nmol/l

—

Hypothyroidism and >3 levothyroxin purchases

335

243

7.86

180.77

1.2

31.27

35.90

nmol/l

—

Anaemias

297

234

8.29

179.40

1.2

38.50

35.90

nmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

1190

2660

2.62

176.41

1.2

23.89

36.73

nmol/l

2.02

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1139

2631

2.60

167.81

1.3

1.2

26.89

37.59

nmol/l

—

Biguanides

1168

2881

2.47

157.01

1.2

24.63

38.05

nmol/l

1.93

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

491

1335

3.76

154.66

1.3

1.2

21.38

34.53

nmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

491

1335

3.76

154.66

1.3

1.2

21.38

34.53

nmol/l

—

Antihypertensive medication - note that there are other indications

706

1114

3.35

153.52

1.2

28.19

41.04

nmol/l

0.67

Cardiovascular diseases (excluding rheumatic etc)

753

1418

3.07

148.16

1.2

28.81

34.89

nmol/l

0.36

Diabetes, insulin treatment (Kela reimbursement)

1187

3020

2.36

144.20

1.3

1.2

26.89

33.93

nmol/l

—

Metabolic disorders

1103

2796

2.39

137.82

1.3

1.2

32.29

32.81

nmol/l

0.03

Tramadol

930

2178

2.59

137.64

1.2

35.38

29.93

nmol/l

—

Sleep disorders (combined)

1214

2765

2.31

135.88

1.2

34.52

28.25

nmol/l

0.60

Episodal and paroxysmal disorders

1177

2605

2.31

130.37

1.2

27.63

35.94

nmol/l

0.63

Depression medications

304

250

6.19

128.82

1.2

32.89

34.27

nmol/l

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

527

1721

3.13

124.20

1.4

1.2

33.80

34.04

nmol/l

—

Abnormalities of breathing

1012

2453

2.38

124.02

1.3

1.2

27.21

36.28

nmol/l

0.73

Neurological diseases, wide definition

318

304

5.32

117.68

1.2

28.43

28.30

nmol/l

—

Any gastric operation

781

1466

2.69

117.66

1.3

1.2

31.88

29.31

nmol/l

0.16

GASTRO-related operations

781

1466

2.69

117.66

1.3

1.2

31.88

29.31

nmol/l

0.16

Malaise and fatigue

636

1846

2.75

113.00

1.3

1.2

38.11

33.00

nmol/l

—

Cardiovascular diseases

648

1239

2.80

106.76

1.2

28.71

37.24

nmol/l

0.49

Codeine

981

2390

2.24

102.98

1.2

36.20

28.83

nmol/l

0.60

Obesity related asthma

495

1751

2.88

101.14

1.2

21.50

36.68

nmol/l

—

Other antidepressants

1046

2491

2.16

99.50

1.2

34.00

38.60

nmol/l

0.20

Neoplasms

737

1547

2.52

99.23

1.2

29.15

31.10

nmol/l

0.12

Disorders of thyroid, IBD co-morbidities

205

236

6.04

99.21

1.2

38.29

28.57

nmol/l

—

Low back pain

862

2597

2.26

98.43

1.3

1.2

40.64

31.95

nmol/l

0.41

Medical observation and evaluation for suspected diseases and conditions

705

1411

2.58

98.33

1.3

1.2

28.08

26.18

nmol/l

0.12

Mood disorders, excluding more controls

1016

2812

2.14

98.26

1.3

1.2

35.07

34.23

nmol/l

0.03

General symptoms and signs

1098

2646

2.09

96.25

1.3

1.2

29.17

29.51

nmol/l

0.02

Neurological diseases

845

1844

2.32

94.36

1.2

28.21

37.86

nmol/l

0.59

Opioids

994

2415

2.14

92.98

1.2

34.19

28.60

nmol/l

0.45

Disorders of gallbladder, biliary tract and pancreas

1063

3286

2.03

90.82

1.2

22.00

34.57

nmol/l

—

Recurrent or chronic depression

475

1153

2.89

89.96

1.3

1.2

27.43

30.14

nmol/l

—

Disorders of the thyroid gland

1009

3220

2.05

89.35

1.3

1.2

35.42

30.31

nmol/l

0.41

Mood disorders

1098

3589

1.97

87.17

1.3

1.2

32.33

34.50

nmol/l

0.12

Disorders of lipoprotein metabolism and other lipidaemias

850

2388

2.18

87.04

1.3

1.2

31.33

31.68

nmol/l

—

Codeine or tramadol medication

1170

3279

1.95

86.88

1.2

35.31

33.61

nmol/l

0.09

Mood [affective] disorders

1095

3589

1.97

86.73

1.3

1.2

32.33

34.50

nmol/l

0.12

Parasetamol

688

1437

2.44

85.85

1.2

31.90

39.04

nmol/l

0.28

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1117

3036

1.97

84.50

1.2

31.00

35.76

nmol/l

0.26

Lower back pain or/and sciatica

1136

3709

1.92

82.81

1.3

1.2

37.40

33.32

nmol/l

0.22

Other soft tissue disorders, not elsewhere classified

971

2723

2.04

82.80

1.2

28.17

31.00

nmol/l

0.18

Depression

1032

3529

1.97

82.72

1.3

1.2

28.19

34.50

nmol/l

0.42

Diseases of oesophagus, stomach and duodenum

1117

3435

1.93

82.47

1.3

1.2

25.23

32.41

nmol/l

0.90

Hypothyroidism, drug reimbursement

153

162

6.70

82.08

1.2

71.83

42.60

nmol/l

—

Used for control exclusion in common control thyroid runs

1017

2549

2.03

82.08

1.2

30.88

30.24

nmol/l

0.05

Asthma, excluding more controls

766

1758

2.26

80.96

1.2

29.77

36.33

nmol/l

0.43

Benzodiazepine use

1064

3746

1.93

80.71

1.3

1.2

32.15

34.64

nmol/l

0.14

Dyspnoea

960

3506

1.99

80.70

1.3

1.2

28.92

32.69

nmol/l

0.29

Depression or dysthymia

666

1549

2.37

79.96

1.3

1.2

36.70

30.14

nmol/l

—

Other heart diseases

457

1081

2.77

79.09

1.2

31.88

32.34

nmol/l

—

Dorsalgia

990

2633

2.01

78.94

1.3

1.2

38.46

31.15

nmol/l

0.38

Persons encountering health services in other circumstances, wide

1128

3039

1.92

78.94

1.2

30.67

35.76

nmol/l

0.31

Insulin medication

596

2118

2.36

78.71

1.3

1.2

32.60

35.97

nmol/l

—

Asthma

787

1867

2.19

77.92

1.2

29.77

36.33

nmol/l

0.43

Symptoms and signs involving the circulatory and respiratory systems

980

2456

2.01

77.73

1.3

1.2

30.05

36.28

nmol/l

0.41

Cardiac arrhythmias

600

1616

2.40

77.64

1.2

23.44

37.94

nmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

250

436

4.01

77.54

1.4

1.1

—

44.00

—

Anxiety disorders, excluding more controls

867

2717

2.05

77.26

1.3

1.2

30.41

34.23

nmol/l

0.20

Headache

701

2504

2.18

76.02

1.2

41.11

29.51

nmol/l

—

Cholelithiasis, broad definition with cholecystitis

909

3057

1.99

75.43

1.2

23.00

36.45

nmol/l

—

Asthma, unspecified (mode), excluding more controls

561

1686

2.40

74.82

1.3

1.2

23.63

36.90

nmol/l

—

Exclusions for E4_PCOS_CONSORTIUM

835

2550

2.06

74.65

1.3

1.2

30.75

35.43

nmol/l

0.26

Hypothyroidism, other/unspecified

914

3067

1.97

73.51

1.3

1.2

45.24

30.30

nmol/l

0.47

Pain in limb

844

2681

2.02

71.39

1.2

27.33

31.00

nmol/l

—

Asthma (mode)

764

1901

2.13

70.84

1.2

29.77

36.33

nmol/l

0.43

Asthma, unspecified (mode)

570

1790

2.32

70.42

1.3

1.2

23.63

36.90

nmol/l

—

Malignant neoplasm of adrenal gland

37.81

68.90

1.3

1.2

—

Anxiety (asthma-related co-morbidities)

669

2415

2.12

67.69

1.2

30.82

33.09

nmol/l

0.11

Hypothyreosis and Thyroxine purchase for inclusion criteria

949

3306

1.89

67.64

1.3

1.2

44.50

30.98

nmol/l

0.44

Selective serotonin reuptake inhibitors

926

2492

1.94

67.50

1.2

29.61

38.60

nmol/l

0.51

Asthma (only as main-diagnosis), excluding more controls

682

1758

2.16

66.77

1.3

1.2

32.15

36.33

nmol/l

0.26

Pain in throat and chest

809

2406

2.00

66.36

1.3

1.2

29.33

31.04

nmol/l

—

Pituitary-dependent Cushing's disease

42.12

65.73

2.7

1.3

—

Other dorsopathies, not elsewhere classified

960

2639

1.90

65.61

1.2

38.15

31.31

nmol/l

0.37

All kidney diseases

994

3639

1.84

65.42

1.3

1.2

25.83

34.93

nmol/l

—

Abdominal and pelvic pain

916

2394

1.93

65.15

1.3

1.2

27.26

29.17

nmol/l

0.17

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

988

3644

1.84

64.84

1.2

39.40

30.36

nmol/l

—

Neurotic, stress-related and somatoform disorders

934

3466

1.87

64.75

1.2

29.74

35.72

nmol/l

0.42

Anxiety disorders

939

3487

1.86

64.07

1.3

1.2

29.74

35.72

nmol/l

0.42

Asthma (only as main-diagnosis)

697

1867

2.10

63.94

1.2

32.15

36.33

nmol/l

0.26

Spondylopathies

756

2227

2.02

63.53

1.3

1.2

35.63

29.30

nmol/l

—

Any reimbursement code in KELA

538

1147

2.37

63.21

1.2

30.31

34.58

nmol/l

0.30

Insulin, intermediate and long-acting

561

2516

2.17

62.98

1.3

1.2

32.60

31.37

nmol/l

—

All anxiety disorders

686

2644

2.03

61.94

1.2

30.82

34.75

nmol/l

0.21

Other diseases of intestines

1017

3142

1.81

61.25

1.2

31.17

34.06

nmol/l

0.18

Pain in joint

543

1499

2.24

59.85

1.2

27.36

24.59

nmol/l

0.17

Persons encountering health services in other circumstances

453

1960

2.31

59.41

1.2

24.67

29.41

nmol/l

—

Hypothyroidism, strict autoimmune

712

2357

2.00

59.34

1.2

50.79

30.28

nmol/l

0.56

Any mental disorder

1009

2828

1.80

57.52

1.3

1.2

36.37

34.23

nmol/l

0.09

Pure hypercholesterolaemia

695

2242

1.98

56.37

1.2

35.50

32.79

nmol/l

—

Chronic lower respiratory diseases

1150

3559

1.71

56.15

1.2

26.42

36.85

nmol/l

0.93

General examination and investigation of persons without complaint and reported diagnosis

582

1411

2.16

55.90

1.3

1.2

35.17

26.18

nmol/l

0.50

Insulin, combination of fast acting with intermediate-acting or long-acting

596

2687

2.03

55.39

1.3

1.2

32.60

32.13

nmol/l

—

Symptoms and signs involving the digestive system and abdomen

880

2394

1.85

55.28

1.2

24.84

29.17

nmol/l

0.61

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

306

537

2.88

52.38

1.2

33.86

31.43

nmol/l

—

Other headache syndromes

428

1929

2.23

51.93

1.3

1.2

33.86

32.11

nmol/l

—

Vocal cord dysfunction

139

289

4.29

51.33

1.4

1.2

—

37.91

—

Pain (limb, back, neck, head abdominally)

610

1512

2.03

50.12

1.2

30.14

24.36

nmol/l

0.49

Oral corticosteroids

1007

3487

1.70

49.60

1.2

43.89

30.33

nmol/l

0.47

Intracranial trauma

497

1589

2.13

49.50

1.2

46.13

30.27

nmol/l

—

Dorsopathies

915

2639

1.76

49.45

1.2

35.32

31.31

nmol/l

0.23

Other anxiety disorders

500

2065

2.08

49.14

1.3

1.2

33.58

34.80

nmol/l

0.05

Psychiatric diseases

862

2420

1.79

49.02

1.3

1.2

34.24

28.68

nmol/l

0.42

Diseases of the musculoskeletal system and connective tissue

460

1028

2.26

48.92

1.2

38.23

25.83

nmol/l

0.84

Polycystic ovarian syndrome, consortium definition

784

2482

1.83

48.65

1.2

30.36

37.70

nmol/l

0.41

Sciatica+with lumbago

512

2235

2.04

48.58

1.3

1.2

26.88

28.91

nmol/l

—

Gastrointestinal diseases

524

1245

2.12

48.09

1.2

34.08

40.29

nmol/l

0.20

Asthma (diagnoses ohter than nonallergic)

843

3933

1.74

47.99

1.3

1.2

26.14

35.76

nmol/l

1.02

Concussion

434

1570

2.16

46.31

1.2

46.13

30.56

nmol/l

—

Abnormalities of heart beat

357

1521

2.30

46.27

1.3

1.2

23.00

35.73

nmol/l

—

Migraine

497

1903

2.05

46.24

1.3

1.2

33.36

34.64

nmol/l

0.05

First line medication for Crohn's disease

1003

3229

1.68

46.20

1.3

1.2

42.32

30.12

nmol/l

0.49

Complications of surgical and medical care, not elsewhere classified

943

3754

1.68

46.03

1.2

33.76

35.07

nmol/l

0.07

Asthma-related infections

581

3003

1.90

45.43

1.2

29.54

30.84

nmol/l

0.08

Asthma, hospital admission 2, infections

581

3003

1.90

45.43

1.2

29.54

30.84

nmol/l

0.08

Excluding asthma or asthma-COPD overlap

699

1886

1.87

45.19

1.2

30.71

36.33

nmol/l

0.44

ILD medications: prednisolone, methylprednisolone, prednisone

1000

3351

1.67

45.17

1.2

43.21

30.10

nmol/l

0.45

Other heart diseases, wide

866

3060

1.72

44.87

1.2

27.25

31.40

nmol/l

0.44

Nerve, nerve root and plexus disorders

992

3611

1.66

44.67

1.2

27.33

36.80

nmol/l

—

Other pulmonary diagnosis

696

1886

1.86

44.42

1.2

30.71

36.33

nmol/l

0.44

Finngen Rheumatological endpoints

872

2903

1.71

43.83

1.2

46.94

27.10

nmol/l

0.74

Other intervertebral disc disorders

730

2442

1.79

43.27

1.3

1.2

28.36

28.22

nmol/l

0.01

Statin medication

629

1889

1.89

43.19

1.2

24.63

32.79

nmol/l

—

Iron deficiency anaemia

430

2053

2.07

43.18

1.3

1.2

43.20

33.06

nmol/l

—

Disorders of skin appendages

520

2697

1.93

43.04

1.2

30.14

31.14

nmol/l

—

Complications of procedures, not elsewhere classified

775

3643

1.72

42.64

1.3

1.2

35.29

32.19

nmol/l

0.20

Asthma, including avohilmo

1077

3705

1.61

42.23

1.2

27.82

37.18

nmol/l

0.75

Other specific joint derangements/joint disorders

686

2384

1.80

41.94

1.2

47.75

28.50

nmol/l

0.41

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

840

3375

1.69

41.55

1.3

1.2

28.67

31.68

nmol/l

—

Abnormal findings on examination of blood, without diagnosis

439

1973

2.03

41.13

1.2

21.17

31.52

nmol/l

—

Non-selective monoamine reuptake inhibitors

354

1565

2.19

40.89

1.3

1.2

34.00

35.80

nmol/l

—

Inflammatory bowel disease treatment related agents

1031

3573

1.61

40.51

1.2

41.00

30.08

nmol/l

0.40

1021

3210

1.62

40.49

1.2

27.28

37.64

nmol/l

0.75

ILD differential diagnosis

683

1901

1.81

40.15

1.2

31.27

36.33

nmol/l

0.35

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

805

2773

1.71

40.11

1.3

1.2

21.75

39.61

nmol/l

1.61

805

2773

1.71

40.11

1.3

1.2

21.75

39.61

nmol/l

1.61

Pain, not elsewhere classified

288

1232

2.36

40.10

1.3

1.2

53.33

32.59

nmol/l

—

448

2260

1.98

39.94

1.2

29.67

31.19

nmol/l

0.08

COPD differential diagnosis

682

1902

1.81

39.85

1.2

31.27

36.33

nmol/l

0.35

COPD/asthma related infections

914

2773

1.66

39.69

1.3

1.2

27.45

39.61

nmol/l

0.86

COPD/asthma/ILD related infections

914

2773

1.66

39.69

1.3

1.2

27.45

39.61

nmol/l

0.86

Examination and observation for other reasons

494

1409

1.99

39.69

1.2

22.38

26.18

nmol/l

—

Insulin, fast-acting

348

1620

2.17

39.45

1.3

1.2

32.60

31.15

nmol/l

—

Generalized anxiety disorder

206

758

2.75

39.33

1.2

24.67

32.21

nmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

776

3085

1.70

39.30

1.2

50.79

32.11

nmol/l

0.49

Nutritional anaemias

468

2342

1.92

37.74

1.3

1.2

43.20

34.38

nmol/l

—

Implicit Sepsis, including avohilmo

752

3199

1.69

37.65

1.3

1.2

28.40

33.82

nmol/l

—

Constipation

813

3339

1.66

37.65

1.2

44.40

31.86

nmol/l

—

ILD medications

996

3396

1.59

37.00

1.2

44.39

30.43

nmol/l

0.46

Hypo-osmolality and hyponatraemia

181

641

2.84

36.67

1.3

1.2

—

44.80

—

Fever of other and unknown origin

484

2241

1.88

36.28

1.2

30.22

30.53

nmol/l

—

Acute upper respiratory infections

935

3529

1.59

36.24

1.2

29.14

38.36

nmol/l

0.68

Autoimmune diseases

956

3050

1.60

36.00

1.2

27.61

31.48

nmol/l

0.42

Symptoms and signs involving the nervous and musculoskeletal systems

545

3057

1.79

35.84

1.2

21.33

32.95

nmol/l

—

Insulin, fast-acting or short human

349

1695

2.08

35.48

1.3

1.2

32.60

31.15

nmol/l

—

Symptoms and signs involving the urinary system

686

3067

1.70

35.35

1.2

21.00

34.55

nmol/l

—

Soft tissue disorders

866

2739

1.63

35.13

1.2

31.44

30.90

nmol/l

0.03

Genitourinary diseases

448

1136

1.99

34.95

1.2

30.45

26.37

nmol/l

0.25

Condition for Implicit Sepsis (Organ dysfunction codes)

771

3267

1.64

34.67

1.3

1.2

28.40

33.74

nmol/l

—

Irritable bowel syndrome

291

1337

2.20

34.29

1.3

1.2

23.13

31.33

nmol/l

—

Other arrhythmias

590

2532

1.75

33.97

1.2

20.29

34.47

nmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

517

1411

1.87

33.66

1.2

29.50

26.18

nmol/l

0.20

Symptoms and signs involving cognition, perception, emotional state and behaviour

871

3689

1.58

33.64

1.2

23.73

32.11

nmol/l

1.54

Autoimmune diseases related-to ILD

767

3987

1.61

33.24

1.2

26.57

35.37

nmol/l

0.73

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

880

3538

1.58

33.08

1.2

33.00

34.63

nmol/l

—

Bronchitis

972

3786

1.55

33.06

1.2

28.56

35.56

nmol/l

0.50

Acute upper respiratory infections of multiple and unspecified sites

703

3110

1.66

33.06

1.2

27.18

37.25

nmol/l

0.72

Other reaction to severe stress, and adjustment disorders

365

1850

1.99

32.96

1.2

29.25

37.92

nmol/l

—

Migraine without aura

204

820

2.51

32.71

1.3

1.2

45.83

33.50

nmol/l

—

Chronic apical periodontitis

985

3601

1.54

32.48

1.2

21.83

35.06

nmol/l

—

Fall on same level

1006

3517

1.53

31.96

1.2

27.86

35.31

nmol/l

0.61

Diseases of the respiratory system

542

1511

1.81

31.89

1.3

1.2

35.79

36.41

nmol/l

0.03

Diseases of pulp and periapical tissues, including avohilmo

877

2882

1.58

31.80

1.2

28.17

35.02

nmol/l

0.40

Irregular menses

502

2123

1.79

31.19

1.2

28.20

36.65

nmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

847

3683

1.56

30.96

1.2

44.33

28.00

nmol/l

1.37

Asthma, hospital admissions , main diagnosis only

730

3991

1.60

30.65

1.2

32.15

30.53

nmol/l

0.10

Lumbar disc prolapse

547

2349

1.73

30.55

1.2

27.30

28.80

nmol/l

—

Hyperkinetic disorders, excluding more controls

127

383

3.13

30.31

1.2

1.1

25.20

30.77

nmol/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

402

2169

1.87

30.20

1.2

19.20

34.64

nmol/l

—

Asthma/COPD (KELA code 203)

828

3559

1.56

30.08

1.2

28.47

36.85

nmol/l

0.61

Cough

355

1717

1.94

29.78

1.2

42.86

34.76

nmol/l

—

Other joint disorders

743

2410

1.61

29.56

1.2

31.87

28.27

nmol/l

0.25

Dental pulpitis, including avohilmo

837

3473

1.55

29.27

1.2

27.29

34.73

nmol/l

0.51

Mental and behavioural disorders due to tobacco

117

376

3.18

28.86

1.4

1.2

—

30.33

—

Smoking dependency

117

378

3.16

28.61

1.4

1.2

—

37.86

—

Other diseases of urinary system

836

3044

1.55

28.32

1.2

37.87

33.57

nmol/l

0.22

Shoulder lesions

634

2318

1.65

28.13

1.2

38.71

35.47

nmol/l

—

Complications of medical and surgical care

656

3694

1.60

28.12

1.2

30.83

33.70

nmol/l

0.19

Dizziness and giddiness

662

3218

1.61

28.02

1.2

22.83

34.80

nmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

883

3820

1.52

27.99

1.3

1.2

21.75

36.28

nmol/l

2.19

Sleep disorders

805

3622

1.54

27.51

1.2

46.50

28.00

nmol/l

1.56

Persons encountering health services for examination and investigation

496

1411

1.77

27.48

1.2

33.50

26.18

nmol/l

0.48

All pneumoniae

884

3820

1.51

27.46

1.3

1.2

21.75

36.28

nmol/l

2.19

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

874

3739

1.50

26.74

1.2

28.00

34.40

nmol/l

0.44

Infections of the skin and subcutaneous tissue

521

3084

1.67

26.73

1.3

1.2

29.00

30.21

nmol/l

—

Cystitis

725

2753

1.57

26.70

1.2

38.69

34.51

nmol/l

0.20

Malignant neoplasm of endocrine gland, including Hilmo

113

373

3.09

26.68

1.2

1.3

—

34.44

—

Other systemic involvement of connective tissue (FG)

246

1148

2.12

26.61

1.2

83.40

34.67

nmol/l

—

Injuries to the knee and lower leg

1017

3765

1.47

26.41

1.2

28.37

36.11

nmol/l

0.58

Pneumonia, organism unspecified

798

3602

1.53

26.34

1.3

1.2

23.30

34.38

nmol/l

—

Dysphagia

225

1041

2.18

26.19

1.3

1.2

23.80

43.55

nmol/l

—

Influenza and pneumonia

911

3809

1.48

25.64

1.3

1.2

21.54

36.56

nmol/l

2.34

Post-traumatic stress disorder

105

340

3.14

25.57

1.2

27.80

41.93

nmol/l

—

Certain infectious and parasitic diseases

819

2704

1.52

25.25

1.3

1.2

32.31

34.06

nmol/l

0.08

Asthma-related pneumonia

316

1672

1.90

25.07

1.3

1.2

19.20

34.08

nmol/l

—

Symptoms and signs concerning food and fluid intake

112

381

2.98

24.92

1.4

1.2

—

39.57

—

Polyarthropathies

546

2134

1.65

24.92

1.2

48.60

30.21

nmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

459

2623

1.70

24.91

1.3

1.2

26.63

33.47

nmol/l

—

Asthma, hospital admissions 3, pneumonia

316

1676

1.89

24.88

1.3

1.2

19.20

34.08

nmol/l

—

Asthma-related pneumonia or sepsis

316

1676

1.89

24.88

1.3

1.2

19.20

34.08

nmol/l

—

Malignant neoplasm of endocrine gland

102

331

3.15

24.85

1.3

1.2

—

34.44

—

Autoimmune diseases excluding thyroid diseases

838

3030

1.50

24.83

1.2

23.92

31.48

nmol/l

1.12

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

852

3834

1.49

24.69

1.3

1.2

22.45

32.25

nmol/l

1.94

Intestinal infectious diseases, including avohilmo, including avohilmo

965

3701

1.46

24.55

1.2

35.47

34.40

nmol/l

0.05

Use of hypnotics and sedatives

897

3501

1.47

23.99

1.2

43.75

31.04

nmol/l

—

Falls/tendency to fall

889

3021

1.48

23.91

1.2

25.54

36.17

nmol/l

0.94

Insomnia

782

3648

1.50

23.79

1.2

46.50

27.30

nmol/l

1.64

Arthrosis

574

1953

1.62

23.43

1.2

33.00

31.46

nmol/l

—

Diseases of the skin and subcutaneous tissue

801

2681

1.50

23.41

1.3

1.2

29.00

34.33

nmol/l

0.48

Exposure to unspecified factor

864

4034

1.46

23.25

1.2

30.89

34.40

nmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

528

3255

1.60

22.77

1.2

30.83

34.12

nmol/l

0.21

Persons encountering health services for specific procedures and health care

902

3689

1.45

22.54

1.2

28.80

34.77

nmol/l

—

External causes of morbidity and mortality

534

1640

1.64

22.52

1.2

32.67

39.15

nmol/l

0.23

Other acute lower respiratory infections

446

2569

1.66

22.42

1.2

40.20

30.15

nmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

779

2856

1.49

22.07

1.2

23.79

30.37

nmol/l

0.98

Abnormal findings on diagnostic imaging of lung

383

2131

1.71

21.54

1.3

1.2

—

35.43

—

Arthropathies

718

2410

1.51

21.51

1.2

33.07

28.27

nmol/l

0.31

Enthesopathies of lower limb, excluding foot

213

1048

2.05

21.23

1.2

40.20

32.60

nmol/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

351

2000

1.74

21.06

1.2

35.11

30.78

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

229

1146

1.99

20.93

1.2

74.57

29.14

nmol/l

—

Diseases of the ear and mastoid process

948

3365

1.42

20.41

1.3

1.2

29.00

35.54

nmol/l

0.52

Adrenomedullary hyperfunction

39.71

20.31

1.2

1.3

—

Injury, poisoning and certain other consequences of external causes

432

1291

1.68

20.30

1.2

37.15

28.69

nmol/l

0.45

Missing teeth due to accident, extraction or parodontitis

518

2968

1.57

20.29

1.3

1.2

36.60

33.43

nmol/l

—

Urinary track infection

561

1793

1.58

20.19

1.2

40.12

35.76

nmol/l

0.18

Acute bronchitis

342

1949

1.73

20.16

1.2

40.20

31.30

nmol/l

—

Artrosis, including avohilmo

656

2386

1.51

20.04

1.2

33.88

32.30

nmol/l

—

Hernia of abdominal wall

379

2276

1.68

19.87

1.2

43.29

30.31

nmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

613

3903

1.49

19.18

1.3

1.2

30.82

31.51

nmol/l

0.04

Thyrotoxicosis, other and/or unspecified

192

946

2.05

19.15

1.3

1.2

40.50

34.31

nmol/l

—

Dermatitis and eczema

918

3900

1.40

19.01

1.3

1.2

29.59

36.52

nmol/l

0.50

Ventral hernia

215

1107

1.96

18.92

1.2

—

31.76

—

Diseases of the digestive system

364

2177

1.67

18.81

1.3

1.2

26.57

31.81

nmol/l

—

Other diseases of upper respiratory tract

866

3199

1.41

18.75

1.3

1.2

29.39

32.21

nmol/l

0.21

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

478

3077

1.56

18.60

1.2

30.83

33.72

nmol/l

0.18

Other diseases of anus and rectum

242

1308

1.86

18.12

1.3

1.2

25.60

33.56

nmol/l

—

Disorders of eyelid, lacrimal system and orbit

715

3656

1.44

18.05

1.2

30.54

32.55

nmol/l

0.12

Mixed hyperlipidaemia

113

4.25

17.96

1.3

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

579

3490

1.49

17.90

1.2

22.33

33.72

nmol/l

—

Certain infectious and parasitic diseases, including avohilmo

559

1842

1.53

17.64

1.3

1.2

31.55

39.40

nmol/l

0.32

Acute sinusitis

446

2600

1.57

17.64

1.2

26.83

36.44

nmol/l

—

Abnormal findings on diagnostic imaging of other body structures

143

652

2.22

17.52

1.3

1.2

—

33.50

—

Bleeding

649

3134

1.46

17.47

1.3

1.2

23.67

35.46

nmol/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

287

1661

1.74

17.33

1.2

30.50

33.88

nmol/l

—

Migraine without aura and triptan purchases

172

850

2.04

17.09

1.4

1.2

45.83

29.90

nmol/l

—

Gingivitis and periodontal diseases

775

2830

1.42

17.09

1.2

26.13

33.26

nmol/l

0.85

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

192

852

1.98

17.08

1.2

23.14

31.08

nmol/l

—

Disturbances of skin sensation

259

1469

1.78

16.84

1.2

28.38

34.28

nmol/l

—

Disorders of synovium and tendon

433

2360

1.56

16.82

1.3

1.2

67.50

33.64

nmol/l

—

Aortic aneurysm

161

766

2.08

16.70

1.4

1.2

—

37.83

—

Follow-up examination after treatment for conditions other than malignant neoplasms

321

1269

1.69

16.46

1.2

22.67

26.18

nmol/l

—

Migraine with aura

203

1076

1.90

16.40

1.2

19.17

31.24

nmol/l

—

Noninfective enteritis and colitis

383

2419

1.59

16.39

1.2

39.83

29.68

nmol/l

—

Other systemic involvement of connective tissue

249

1408

1.78

16.38

1.2

83.40

32.39

nmol/l

—

Caries of dentine, including avohilmo

575

1987

1.48

16.06

1.2

30.54

44.93

nmol/l

0.76

Other disorders of kidney and ureter

119

523

2.30

15.98

1.2

—

42.60

—

Polyuria

176

900

1.97

15.89

1.3

1.2

—

34.58

—

Intestinal infectious diseases

759

4081

1.39

15.73

1.2

35.00

34.04

nmol/l

—

Systemic connective tissue disorders

298

1794

1.67

15.64

1.2

83.40

36.69

nmol/l

—

Disturbance of activity and attention

126

559

2.22

15.52

1.2

25.20

32.68

nmol/l

—

Viral hepatitis, IBD co-morbidity

4.97

15.46

1.5

1.3

—

27.20

—

Hernia

741

3548

1.39

15.43

1.2

34.67

31.88

nmol/l

0.20

Fracture of lower leg, including ankle

447

2914

1.51

15.32

1.2

24.43

33.83

nmol/l

—

Gastroduodenal ulcer

186

978

1.91

15.31

1.2

—

35.67

—

Haemorrhoids and perianal venous thrombosis

257

1495

1.72

14.91

1.3

1.2

31.14

33.56

nmol/l

—

Thoracic aortic aneurysm

114

507

2.27

14.90

1.3

1.2

—

40.20

—

Chronic pancreatitis

108

474

2.30

14.59

1.3

1.2

—

44.20

—

Other sleep disorders

395

2.43

14.49

1.2

—

36.20

—

Diseases of pulp and periapical tissues and dental caries

459

1553

1.52

14.48

1.2

36.00

45.65

nmol/l

—

Visual disturbances and blindness

419

2782

1.51

14.40

1.2

30.00

33.48

nmol/l

—

Excessive, frequent and irregular menstruation

329

1078

1.64

14.30

1.2

39.88

33.38

nmol/l

—

Hyperkinetic disorders

128

593

2.12

14.14

1.2

25.20

32.68

nmol/l

—

Primary gonarthrosis, bilateral

396

2174

1.53

14.13

1.2

1.3

—

42.50

—

Thyrotoxicosis

233

1352

1.74

14.10

1.3

1.2

38.29

33.86

nmol/l

—

Other external causes of accidental injury

615

2165

1.43

14.08

1.2

33.15

37.95

nmol/l

0.21

Dermatitis

506

3436

1.45

13.88

1.3

1.2

32.82

32.05

nmol/l

0.03

Accidents

613

2165

1.42

13.80

1.2

36.08

37.95

nmol/l

0.07

Other follicular disorders

312

2.57

13.51

1.2

—

37.63

—

Urticaria and erythema

310

1957

1.59

13.49

1.2

24.89

31.50

nmol/l

—

Trochanteric bursitis

137

684

2.02

13.36

1.3

1.2

—

34.88

—

Hidradenitis suppurativa

145

3.38

13.33

1.1

1.2

—

31.40

—

Other and unspecified tonsillitis

263

1320

1.66

13.31

1.3

1.2

19.50

38.19

nmol/l

—

Diseases of the eye and adnexa

605

2147

1.42

13.30

1.2

29.82

37.30

nmol/l

0.42

Septicaemia

308

1770

1.59

13.29

1.3

1.2

—

33.08

—

Candidiasis, including avohilmo

268

1641

1.64

13.26

1.3

1.2

32.17

32.61

nmol/l

—

Other and unspecified dermatitis

430

2928

1.47

13.16

1.2

32.82

33.35

nmol/l

0.02

Explicit Sepsis

328

1918

1.56

13.08

1.3

1.2

—

34.40

—

Injuries to the ankle and foot

590

3632

1.39

12.88

1.2

29.69

33.95

nmol/l

0.25

Nontoxic single thyroid nodule

308

2.54

12.86

1.2

—

31.00

—

Disorders of conjunctiva

677

3859

1.36

12.83

1.2

26.73

35.77

nmol/l

0.77

Problems related to lifestyle

399

2.33

12.83

1.2

—

34.33

—

Explicit Sepsis, including avohilmo

334

1964

1.55

12.73

1.3

1.2

—

33.74

—

Use of cabergoline

5.66

12.69

1.3

1.1

—

Internal derangement of knee

285

1773

1.60

12.66

1.2

33.67

32.80

nmol/l

—

Dental caries, including avohilmo

509

1811

1.44

12.50

1.2

32.70

45.72

nmol/l

—

Other septicaemia, including avohilmo

282

1661

1.60

12.50

1.3

1.2

—

31.54

—

Unknown and unspecified causes of morbidity

243

2.71

12.43

1.3

1.2

—

39.00

—

GI-bleeding

222

1318

1.69

12.38

1.3

1.2

30.60

33.27

nmol/l

—

Other septicaemia

275

1622

1.61

12.37

1.3

1.2

—

31.54

—

Intracranial injury

448

2896

1.45

12.34

1.2

42.00

29.78

nmol/l

—

Psychotic depression

173

3.04

12.30

1.3

1.2

—

25.00

—

Hyperkalaemia

154

3.16

12.08

1.2

—

Injuries to the head

872

3964

1.31

12.01

1.2

47.80

30.59

nmol/l

0.48

Other disorders of ear

703

3387

1.34

11.92

1.2

31.40

33.06

nmol/l

—

Visual disturbances

386

2629

1.48

11.88

1.2

30.00

33.42

nmol/l

—

Cardiodefibrillation

241

1478

1.63

11.76

1.2

—

38.78

—

Other disorders of lacrimal gland

306

1994

1.54

11.69

1.3

1.2

19.60

34.04

nmol/l

—

Other diseases of the digestive system

222

1340

1.67

11.67

1.3

1.2

30.60

33.27

nmol/l

—

Ovarian cyst

290

1046

1.59

11.59

1.2

26.89

31.74

nmol/l

—

Pure hyperglyceridaemia

4.37

11.54

1.4

1.1

—

Peripheral artery disease

284

1430

1.58

11.51

1.4

1.2

—

37.09

—

Disease of hard tissues of teeth, NOS

389

1367

1.49

11.51

1.2

39.71

32.41

nmol/l

—

Weight loss

439

2.19

11.45

1.4

1.2

—

28.80

—

Cluster headache, strict

109

3.55

11.45

1.1

1.3

—

30.40

—

Superficial injury of lower leg

217

1310

1.67

11.43

1.3

1.2

25.14

30.63

nmol/l

—

Noninflammatory disorders of female genital tract

331

1078

1.55

11.37

1.2

30.93

33.38

nmol/l

0.13

Abnormal involuntary movements

114

566

2.03

11.37

1.2

—

39.90

—

Diseases of external ear

276

1770

1.57

11.34

1.2

26.83

34.75

nmol/l

—

Bulimia nervosa (incl. atypical)

130

3.29

11.27

1.3

—

25.22

—

Non-invasive ventilation

131

590

1.92

11.00

1.2

—

35.27

—

Other inflammation of eyelid, including avohilmo

372

2557

1.46

10.97

1.2

34.09

30.02

nmol/l

0.22

Inflammatory diseases of female pelvic organs

550

2744

1.38

10.96

1.3

1.2

36.20

36.22

nmol/l

—

Pregnancy hypertension

361

2203

1.47

10.86

1.2

54.63

31.80

nmol/l

—

Hypotension

126

659

1.93

10.82

1.2

—

33.14

—

Triptan medication for migraine, min. 3 purchases

483

2588

1.40

10.80

1.2

47.50

31.67

nmol/l

—

Adjustment and management of implanted device

128

674

1.91

10.78

1.2

—

37.13

—

Other and unspecified effects of external causes

225

1394

1.62

10.73

1.2

26.33

33.03

nmol/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

188

1113

1.70

10.73

1.2

36.80

32.20

nmol/l

—

Conjunctivitis

609

3662

1.34

10.63

1.2

26.73

35.85

nmol/l

0.78

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

311

2051

1.50

10.58

1.2

35.11

29.79

nmol/l

—

Epilepsy

193

1150

1.68

10.57

1.2

—

34.65

—

Cluster headache, wide

120

3.30

10.57

1.1

1.3

—

30.40

—

Thyroiditis, ILD-related definition

110

555

2.00

10.54

1.3

1.2

—

33.21

—

Bell's palsy

474

2.09

10.53

1.2

—

41.50

—

Gastric ulcer

125

660

1.91

10.45

1.3

1.2

—

42.60

—

Mental and behavioural disorders due to sedatives or hypnotics

279

2.43

10.35

1.5

1.2

—

28.80

—

Triptan medication for migraine, single purchase ok

621

3153

1.34

10.34

1.3

1.2

43.53

30.77

nmol/l

0.81

Migraine, single triptan purchase ok & required. ICD-code if available is included

621

3153

1.34

10.34

1.3

1.2

43.53

30.77

nmol/l

0.81

Injuries to the shoulder and upper arm

647

3776

1.32

10.30

1.2

23.50

32.91

nmol/l

—

ILD medications: immunosuppressive drugs

479

3146

1.38

10.30

1.2

57.00

30.37

nmol/l

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

700

4170

1.31

10.27

1.2

26.50

34.87

nmol/l

—

Benign neoplasm: Colon, unspecified

187

1121

1.68

10.19

1.2

—

38.44

—

Other symptoms and signs involving the urinary system

364

2.22

10.06

1.3

—

34.50

—

Otitis externa

185

1110

1.68

10.06

1.2

26.83

33.55

nmol/l

—

Other CVD

140

777

1.81

10.02

1.2

—

39.37

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

392

2394

1.43

9.99

1.2

54.63

32.19

nmol/l

—

Exposure to other specified factors

628

4089

1.32

9.98

1.2

33.71

33.08

nmol/l

0.03

Conjunctivitis (acute, non atopic), including avohilmo

771

3604

1.29

9.98

1.2

30.65

36.78

nmol/l

0.40

Disorders of lacrimal system

349

2386

1.44

9.75

1.3

1.2

19.60

36.47

nmol/l

—

Retention of urine

216

1089

1.61

9.74

1.3

1.2

—

37.86

—

Dental operations

418

1519

1.42

9.55

1.2

33.71

45.79

nmol/l

—

Urticaria

242

1570

1.55

9.53

1.3

1.2

21.50

33.12

nmol/l

—

Gout, FINNGEN

187

1134

1.65

9.51

1.2

1.3

—

40.43

—

Mycoses, including avohilmo

708

4175

1.29

9.50

1.3

1.2

26.40

35.08

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

253

1292

1.54

9.50

1.4

1.2

—

39.63

—

Other neurological diseases

521

3003

1.35

9.42

1.3

1.2

28.43

36.40

nmol/l

—

Gout, idiopatic and unspecified

161

951

1.70

9.31

1.2

1.3

—

35.00

—

Other diseases of hard tissues of teeth

380

1377

1.43

9.21

1.2

34.83

32.41

nmol/l

—

Menorrhagia

269

983

1.53

9.18

1.2

35.80

37.29

nmol/l

—

Monoamine oxidase A inhibitors

440

2.04

9.08

1.3

1.2

—

30.17

—

Transport accidents

342

1993

1.43

8.99

1.2

33.89

37.15

nmol/l

—

Tonsillectomy and adenotomy

432

2182

1.38

8.97

1.2

27.13

35.50

nmol/l

0.63

Diabetes mellitus in pregnancy

277

1174

1.51

8.96

1.2

27.18

36.59

nmol/l

0.51

Gout, unspecified

132

747

1.78

8.92

1.3

—

35.00

—

Other disorders of skin and subcutaneous tissue

542

3458

1.33

8.89

1.3

1.2

64.38

32.83

nmol/l

—

Hypertensive Renal Disease

3.95

8.88

1.5

1.1

—

Diseases of salivary glands

258

1728

1.50

8.81

1.3

1.2

21.67

34.43

nmol/l

—

Chronic sinusitis

321

2240

1.44

8.79

1.2

37.00

34.22

nmol/l

—

Other hearing loss

191

1160

1.60

8.72

1.2

—

33.08

—

Conduction disorders

193

965

1.61

8.72

1.2

34.60

31.67

nmol/l

—

Diseases of oral cavity, salivary glands and jaws

378

1379

1.42

8.60

1.2

36.00

32.41

nmol/l

—

Acne, including avohilmo

167

826

1.64

8.26

1.2

38.75

30.86

nmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

197

2.52

8.25

1.3

1.2

—

28.80

—

Other diseases of intestine

113

626

1.82

8.24

1.2

—

39.22

—

Special screening examination for infectious and parasitic diseases

161

710

1.66

8.15

1.3

1.2

38.25

25.26

nmol/l

—

Hypertrophy of breast in women and men

172

1073

1.61

8.14

1.2

26.67

35.64

nmol/l

—

Migraine with aura and triptan purchases

138

816

1.70

8.04

1.2

20.20

29.90

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

229

1527

1.51

8.04

1.2

74.57

30.23

nmol/l

—

Fracture of shoulder and upper arm

261

1789

1.46

7.92

1.2

21.20

30.38

nmol/l

—

Umbilical hernia

193

1247

1.56

7.85

1.3

1.2

43.29

30.22

nmol/l

—

Injuries to the elbow and forearm

539

3556

1.30

7.84

1.2

27.50

31.80

nmol/l

—

Conjunctivitis (acute, non atopic)

217

1434

1.51

7.79

1.2

25.17

33.75

nmol/l

—

Unspecified fall

366

2625

1.37

7.75

1.2

27.38

32.18

nmol/l

—

Chronic diseases of tonsils and adenoids

581

2841

1.29

7.65

1.2

29.24

32.05

nmol/l

0.21

Dentofacial anomalies [including malocclusion]

557

3377

1.29

7.62

1.2

26.64

34.25

nmol/l

0.66

Conductive and sensorineural hearing loss

558

2862

1.30

7.61

1.3

1.2

31.40

34.39

nmol/l

—

Gestational diabetes (for exclusion)

302

1464

1.42

7.55

1.2

24.89

36.60

nmol/l

—

Benign neoplasm: Pancreas

108

3.02

7.55

1.2

—

Other noninflammatory disorders of uterus, except cervix

169

705

1.61

7.44

1.3

1.2

—

29.60

—

Medical abortion

511

2113

1.31

7.36

1.2

34.44

34.86

nmol/l

—

Vasomotor and allergic rhinitis

279

1924

1.42

7.30

1.3

1.2

21.56

30.03

nmol/l

—

Other diseases of lip and oral mucosa

325

2357

1.38

7.29

1.3

1.2

23.20

34.00

nmol/l

—

Major coronary heart disease event excluding revascularizations

394

1926

1.35

7.25

1.3

1.2

—

39.19

—

Heart failure and coronary heart disease

261

1268

1.45

7.14

1.2

—

40.25

—

Psoriatic and enteropathic arthropathies

473

1.87

7.14

1.2

29.00

34.50

nmol/l

—

Special screening examination for other diseases and disorders

445

1.90

7.10

1.3

1.2

—

28.20

—

Other viral diseases, not elsewhere classified, including avohilmo

202

1343

1.50

7.03

1.3

1.2

23.20

32.57

nmol/l

—

Peroneal tendinitis

3.93

7.02

1.4

1.1

—

Endometriosis

256

1028

1.45

6.96

1.3

1.2

25.00

32.44

nmol/l

—

Superficial injury of abdomen, lower back and pelvis

119

711

1.68

6.75

1.2

43.40

34.69

nmol/l

—

Diseases of male genital organs

267

937

1.44

6.72

1.2

23.00

18.71

nmol/l

—

Other congenital malformations

364

1.97

6.66

1.1

1.2

—

33.00

—

Tinnitus

176

1159

1.53

6.66

1.2

—

30.04

—

Cluster headache, strict, including avohilmo

212

2.29

6.65

1.1

1.2

—

29.29

—

Zoster [herpes zoster]

132

816

1.63

6.57

1.2

—

34.78

—

Dislocation, sprain and strain of joints and ligaments of knee

451

3153

1.30

6.48

1.2

26.20

30.94

nmol/l

—

Cluster headache, wide,, including avohilmo

222

2.23

6.40

1.1

1.2

—

29.29

—

Suicide or other Intentional self-harm

181

1210

1.50

6.39

1.2

46.00

30.31

nmol/l

—

Suppurative and unspecified otitis media

264

1676

1.40

6.31

1.3

1.2

29.25

30.20

nmol/l

—

Leiomyoma of uterus

496

2167

1.29

6.31

1.3

1.2

40.22

31.29

nmol/l

—

Papulosquamous disorders

284

2074

1.37

6.19

1.2

17.75

35.18

nmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

115

698

1.66

6.19

1.2

—

33.89

—

Psoriasis

208

1439

1.45

6.19

1.2

18.29

33.87

nmol/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

353

2640

1.33

6.18

1.2

19.33

31.11

nmol/l

—

Abdominal aortic aneurysm (AAA)

230

2.17

6.14

1.4

1.2

—

Symptoms and signs involving speech and voice

241

1716

1.41

6.12

1.3

1.2

25.20

34.75

nmol/l

—

Poisoning by drugs, medicaments and biological substances

177

1196

1.49

5.97

1.2

47.60

29.50

nmol/l

—

Other and unspecified urticaria

150

980

1.54

5.94

1.3

1.2

20.57

37.00

nmol/l

—

Injuries to the hip and thigh

322

2160

1.34

5.92

1.3

1.2

43.29

31.77

nmol/l

—

Myocardial infarction

302

1555

1.36

5.91

1.3

1.2

—

35.36

—

Other symptoms and signs involving cognitive functions and awareness

306

2015

1.35

5.89

1.3

1.2

31.60

36.43

nmol/l

—

Outcome of delivery

627

0.50

5.89

1.1

1.2

42.00

29.11

nmol/l

—

Unspecified kidney failure

325

1.95

5.86

1.3

1.2

—

Cerebral palsy and other paralytic syndromes

454

1.80

5.83

1.3

1.2

—

37.86

—

Acute appendicitis, no complications

397

3053

1.30

5.82

1.2

44.60

29.42

nmol/l

—

Acromegaly and pituitary gigantism

6.38

5.78

1.1

1.2

—

Periapical abscess

332

2512

1.33

5.76

1.2

26.33

32.32

nmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

254

1149

1.40

5.75

1.2

27.50

30.77

nmol/l

—

Infections with a predominantly sexual mode of transmission, including avohilmo

300

2044

1.35

5.72

1.3

1.2

35.13

32.43

nmol/l

—

Persons encountering health services for specific procedures, not carried out

364

1.88

5.68

1.2

—

33.10

—

Pregnancy with abortive outcome

516

2131

1.26

5.66

1.2

41.73

34.95

nmol/l

0.30

Fall on same level involving ice and snow

420

3285

1.28

5.66

1.2

40.17

31.29

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

261

2.05

5.64

1.2

—

37.83

—

Injuries to the neck

167

1129

1.49

5.64

1.2

29.17

32.38

nmol/l

—

Unspecified acute lower respiratory infection

105

639

1.65

5.63

1.3

1.2

—

34.79

—

Other obstetric conditions, not elsewhere classified

257

1180

1.38

5.41

1.2

27.50

30.51

nmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

423

3158

1.27

5.39

1.2

29.67

33.39

nmol/l

—

Other viral diseases, including avohilmo

270

1983

1.35

5.38

1.3

1.2

21.86

30.00

nmol/l

—

Scabies, including avohilmo

113

709

1.60

5.38

1.3

1.2

18.40

34.29

nmol/l

—

Disorders of sclera, cornea, iris and ciliary body

388

3031

1.28

5.34

1.2

33.20

31.35

nmol/l

—

Ulcer of lower limb, not elsewhere classified

565

1.67

5.31

1.3

1.2

—

44.80

—

In situ neoplasms

278

2080

1.34

5.26

1.3

1.2

—

35.53

—

Appendectomy

471

3587

1.25

5.26

1.2

42.17

32.45

nmol/l

—

Gestational [pregnancy-induced] hypertension

203

1444

1.41

5.21

1.2

65.17

33.36

nmol/l

—

Injuries to the wrist and hand

740

4096

1.20

5.18

1.2

29.91

34.61

nmol/l

0.24

Pediculosis, acariasis and other infestations, including avohilmo

128

841

1.53

5.01

1.3

1.2

21.83

35.15

nmol/l

—

Lateral epicondylitis

570

1.64

4.91

1.2

—

34.11

—

Neuroendocrine tumor and carcinoma of pancreas

5.95

4.82

1.3

1.1

—

Pre-eclampsia or poor fetal growth

238

1759

1.35

4.79

1.2

29.80

30.77

nmol/l

—

Follicular cysts of skin and subcutaneous tissue

126

836

1.51

4.74

1.2

—

36.67

—

Diseases of appendix

528

3868

1.22

4.73

1.2

38.63

33.20

nmol/l

—

Glomerulonephritis

380

1.78

4.72

1.2

—

37.86

—

Otalgia

366

1.79

4.69

1.3

1.2

—

36.89

—

Acute appendicitis

493

3729

1.23

4.68

1.2

39.43

33.20

nmol/l

—

Pyogenic arthritis

225

2.01

4.65

1.2

—

41.83

—

Excessive attrition of teeth

448

3584

1.24

4.65

1.2

32.57

33.53

nmol/l

—

Diseases of the myoneural junction and muscle

487

1.67

4.64

1.3

1.2

—

41.83

—

Neuromuscular dysfunction of bladder

339

1.81

4.61

1.1

1.2

—

42.00

—

Recurrent dislocation and subluxation of joint

275

1.91

4.59

1.2

1.3

—

35.67

—

Anankastic personality disorder

160

2.21

4.57

1.1

1.2

—

28.80

—

Allergic rhinitis

219

1597

1.36

4.57

1.3

1.2

21.56

31.71

nmol/l

—

Diseases of middle ear and mastoid

400

2614

1.25

4.46

1.3

1.2

29.17

33.56

nmol/l

0.26

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

459

3403

1.23

4.44

1.2

29.67

33.39

nmol/l

—

Appendicitis, broad definition

520

3845

1.22

4.43

1.2

39.43

33.20

nmol/l

—

Malignant neoplasm of other endocrine glands and related structures

12.79

4.38

1.1

1.2

—

Maternal care for other conditions predominantly related to pregnancy

159

1096

1.42

4.34

1.1

1.2

29.20

38.45

nmol/l

—

Disorders of breast

387

2729

1.25

4.33

1.2

25.71

33.54

nmol/l

—

Charcot foot

3.09

4.26

1.4

1.2

—

Other maternal disorders predominantly related to pregnancy

440

2232

1.24

4.23

1.2

30.91

37.14

nmol/l

0.26

Atopic dermatitis

430

2781

1.23

4.20

1.3

1.2

27.13

35.96

nmol/l

0.67

Personal history of other diseases and conditions

514

1.62

4.19

1.2

—

36.18

—

Morphin

2.94

4.18

1.2

1.1

—

Fatigue fracture of vertebra

8.28

4.10

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

405

3148

1.23

4.09

1.2

27.78

35.02

nmol/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

390

1.70

4.08

1.3

1.2

—

34.89

—

Other specified and unspecified disorders of eyelid

3.25

4.08

1.3

1.2

—

Tobacco use

216

1.96

4.07

1.3

1.2

—

28.80

—

Stroke, excluding SAH

369

2135

1.25

4.03

1.3

1.2

—

37.57

—

Female infertility

209

929

1.35

4.00

1.3

1.2

21.00

31.33

nmol/l

—

Cramp and spasm

190

2.02

3.99

1.2

—

28.80

—

Benign neoplasm of middle ear and respiratory system

304

1.79

3.97

1.2

—

43.00

—

Nephropathy related operations

470

1.63

3.96

1.2

—

35.00

—

Allergic conjunctivitis

426

3358

1.22

3.95

1.2

27.78

33.65

nmol/l

—

Other and unspecified drugs and medicaments

380

1.70

3.91

1.3

1.2

—

36.00

—

Stroke, including SAH

392

2279

1.24

3.90

1.3

1.2

—

39.27

—

Acute suppurative otitis media

182

1251

1.36

3.88

1.3

1.2

24.43

30.43

nmol/l

—

Herpesviral [herpes simplex] infections

536

1.58

3.86

1.2

—

32.56

—

Other and unspecified injuries of ankle and foot

166

2.07

3.81

1.1

1.2

—

37.17

—

Dissociative [conversion] disorders

146

2.14

3.81

1.2

1.1

—

36.50

—

Abscess of Bartholin gland

127

2.24

3.79

1.3

—

30.33

—

Carcinoma in situ, bladder

121

2.26

3.75

1.3

1.2

—

Meralgia paraesthetica

128

2.21

3.71

1.1

1.2

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

318

1.74

3.71

1.2

1.3

—

33.82

—

Reimbursement for rheumatic diseases

390

3174

1.22

3.69

1.2

55.29

35.82

nmol/l

—

Collapsed vertebra, not elsewhere classified

5.76

3.68

1.4

1.3

—

Fluid overload

8.17

3.61

1.1

1.3

—

Crohn's disease of large intestine

212

1.90

3.59

1.2

—

27.83

—

Second line medication for Crohn's disease

401

3302

1.22

3.57

1.2

53.50

33.48

nmol/l

—

Idiopathic hypercalciuria

4.40

3.56

1.4

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

115

801

1.44

3.51

1.4

1.3

—

40.88

—

Temporomandibular joint disorders, including avohilmo

332

2609

1.24

3.45

1.2

26.89

34.11

nmol/l

—

Sequelae of injuries of lower limb

394

1.63

3.45

1.1

1.2

—

36.00

—

Infections with a predominantly sexual mode of transmission

216

1668

1.30

3.38

1.2

36.80

28.98

nmol/l

—

Superficial injury of thorax

651

1.48

3.38

1.3

1.2

—

33.14

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

115

808

1.43

3.36

1.2

—

31.80

—

Atopic dermatitis, strict definition with reimbursement

208

1540

1.30

3.35

1.2

30.11

32.86

nmol/l

—

Myocardial infarction, strict

258

1439

1.27

3.34

1.2

—

37.20

—

Carcinoid syndrome

4.02

3.31

1.5

1.2

—

Hyperosmolality and hypernatraemia

3.07

3.27

1.4

1.1

—

L04AX Other immunosuppressants

384

3182

1.21

3.26

1.2

58.63

33.77

nmol/l

—

Other disorders starting during childhood or adolecense, excluding more controls

116

2.15

3.25

1.1

—

25.14

—

Deviated nasal septum

190

1452

1.31

3.25

1.2

30.00

30.75

nmol/l

—

Carcinoma in situ of other and unspecified sites

129

2.11

3.25

1.3

—

Open wound of forearm

394

1.61

3.21

1.2

—

31.75

—

Fracture of forearm

385

2873

1.21

3.17

1.2

27.50

33.15

nmol/l

—

Haemorrhage, not elsewhere classified

117

2.15

3.17

1.3

1.2

—

Focal epilepsy

128

927

1.38

3.16

1.2

—

32.14

—

Gout due to impairment of renal function

3.50

3.13

1.1

1.2

—

Calcaneal spur

2.85

3.11

1.2

—

Sequelae of cerebrovascular disease

201

1330

1.29

3.09

1.2

—

32.36

—

Liquid cancers, including Hilmo

206

1412

1.29

3.09

1.2

—

36.25

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

142

1020

1.35

3.05

1.2

1.3

—

34.15

—

Ischaemic Stroke, excluding all haemorrhages

334

2018

1.22

3.04

1.3

1.2

—

36.82

—

Striking against or struck by other objects

212

1661

1.28

3.02

1.2

—

30.90

—

Spermatocele

211

1.81

3.00

1.2

1.3

—

Other disorders of cornea

434

1.55

2.97

1.1

1.2

—

41.83

—

Calcific aortic valvular stenosis, including rheumatic fever

150

1083

1.33

2.95

1.2

1.3

—

36.00

—

Other osteochondrodysplasias, including avohilmo

2.88

2.94

1.2

—

Supervision of normal pregnancy

758

0.70

2.92

1.2

29.40

28.74

nmol/l

—

Systemic sclerosis (FG)

2.40

2.90

1.2

1.3

—

Calcific aortic valvular stenosis

149

1079

1.33

2.90

1.2

1.3

—

36.00

—

Calcific aortic valvular stenosis, operated

149

1079

1.33

2.90

1.2

1.3

—

36.00

—

Calcific aortic valvular stenosis, diagnosis (helper)

149

1079

1.33

2.90

1.2

1.3

—

36.00

—

Operations 2 for CAVS

149

1079

1.33

2.90

1.2

1.3

—

36.00

—

Magnesium deficiency

6.94

2.90

1.2

—

Left side

6.90

2.89

1.3

—

Malignant neoplasm of thyroid gland, including Hilmo

344

1.61

2.85

1.2

—

34.44

—

Postzoster neuralgia

2.80

2.83

1.4

1.1

—

Ovarian dysfunction: androgen excess

8.94

2.80

1.0

1.3

—

Focal epilepsy, strict definition

115

838

1.38

2.79

1.2

—

32.06

—

Benign neoplasm: Endocrine gland, other/unspecified

5.23

2.77

1.3

1.1

—

Myocardial infarction, without ST-elevation

212

1518

1.26

2.75

1.3

1.2

—

37.40

—

Abnormality of white blood cells, not elsewhere classified

3.31

2.75

1.0

1.2

—

Other peripheral vertigo

419

1.54

2.74

1.2

—

41.83

—

Malignant neoplasm of thyroid gland

317

1.62

2.73

1.2

—

34.44

—

malignant neoplasm of male genital organs, including Hilmo

131

581

1.36

2.71

1.3

1.2

—

33.40

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

4.35

2.71

1.1

1.2

—

Urethral stricture

160

1.89

2.71

1.2

—

Pollen allergy

125

915

1.35

2.70

1.3

1.2

21.88

33.10

nmol/l

—

Ankylosing spondylitis

302

1.63

2.70

1.2

—

34.00

—

Nonsuppurative otitis media, including avohilmo

207

1422

1.26

2.66

1.2

29.83

30.72

nmol/l

—

Acidosis

2.49

2.63

1.3

1.1

—

Inflammatory disorders of male genital organs, not elsewhere classified

3.38

2.61

1.4

1.1

—

malignant neoplasm of male genital organs

127

566

1.35

2.61

1.3

1.2

—

33.40

—

ILD, hospital admissions 3, with pneumonia sepsis

282

1.64

2.60

1.3

1.2

—

Unstable angina pectoris

196

1218

1.27

2.59

1.3

1.2

—

40.25

—

Protein-energy malnutrition of moderate and mild degree

3.66

2.59

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

409

1.52

2.58

1.2

—

35.71

—

Papillary adenocarcinoma of thyroid gland

245

1.69

2.57

1.2

—

37.83

—

Other embolism and thrombosis

540

1.45

2.56

1.3

1.2

—

36.00

—

Discitis, unspecified

2.76

2.56

1.1

1.3

—

Acute laryngitis and tracheitis

459

1.48

2.55

1.3

1.2

24.40

33.67

nmol/l

—

Other osteochondrodysplasias

3.29

2.54

1.1

1.2

—

Other congenital malformations of skin

150

1.88

2.52

1.1

1.2

—

28.80

—

Liquid cancers

159

1168

1.29

2.52

1.2

1.3

—

31.87

—

Dermatophytosis, including avohilmo

437

3682

1.16

2.52

1.2

20.67

30.31

nmol/l

—

Congenital hypothyroidism without goiter

4.50

2.50

1.0

1.3

—

Abnormal reflex

4.50

2.50

1.0

1.1

—

Other congenital malformations, including avohilmo

593

1.42

2.49

1.1

1.2

—

35.33

—

Vulvovaginal ulceration/inflammation in other diseases

357

1.55

2.48

1.2

—

38.13

—

Dronedarone medication

2.10

2.44

1.3

1.2

—

Iliotibial band syndrome

3.38

2.40

1.3

—

Congenital malformation of biliary tract

6.50

2.40

1.0

1.1

—

Malignant neoplasm of tonsil and base of tongue

2.44

2.38

1.3

1.2

—

Multiple delivery

476

0.56

2.35

1.2

—

33.45

—

Other specified/unspecified spondylopathies

2.33

2.32

1.5

1.2

—

Atopic dermatitis, strict definition

195

1536

1.24

2.32

1.2

30.11

31.45

nmol/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.55

2.29

1.3

1.2

—

Other rupture of muscle

3.96

2.26

1.3

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

623

1.39

2.24

1.3

—

39.22

—

Sudden idiopathic hearing loss

415

1.48

2.24

1.2

—

37.83

—

Benign neoplasm: Carotid body

5.75

2.23

1.0

1.3

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.91

2.22

1.5

1.3

—

Secondary parkinsonism, excluding more controls

2.52

2.19

1.3

1.2

—

Mild or no visual impairment, binocular

3.78

2.17

1.1

1.2

—

Autism spe, excluding more controls

2.25

2.17

1.1

—

31.00

—

Acute thyroiditis

4.41

2.17

1.3

1.1

—

Keratoconus

2.04

2.17

1.0

1.2

—

Thyroiditis

329

1.53

2.16

1.3

1.2

—

29.67

—

Other and unspecified glaucoma

250

1.61

2.15

1.4

1.2

—

Dermatopolymyositis (FG)

2.65

2.15

1.4

1.2

—

Injuries to unspecified part of trunk, limb or body region

428

1.45

2.13

1.1

1.2

—

34.78

—

Paraplegia, diplegia of upper limbs

2.23

2.12

1.3

1.1

—

Other and unspecified disorders of pigmentation

3.26

2.11

1.1

1.2

—

Agranulocytosis

496

1.42

2.10

1.2

—

35.71

—

Sarcoidosis

589

1.38

2.09

1.2

—

29.40

—

Benign neoplasm: Heart

5.16

2.09

1.6

1.3

—

Universal erythroderma, KELA reimbursement

2.59

2.09

1.1

1.2

—

Congenital malformations of gallbladder, bile ducts and liver

2.75

2.08

1.1

1.2

—

Kyphosis

2.94

2.08

1.0

1.3

—

Drug-induced headache, not elsewhere classified

3.58

2.07

1.3

1.2

—

Biological medication for rheuma

117

901

1.30

2.06

1.1

1.2

23.33

30.71

nmol/l

—

Antenatal screening

106

780

0.76

2.06

1.1

1.2

34.50

30.25

nmol/l

—

Paget disease

4.10

2.05

1.3

1.2

—

Malignant neoplasm of floor of mouth, including Hilmo

2.86

2.01

1.4

1.2

—

Impotence

163

1.73

1.98

1.4

1.2

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

3.40

1.98

1.0

1.2

—

Idiopathic peripheral autonomic neuropathy

4.67

1.96

1.4

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.60

1.95

1.5

1.2

—

Acquired stenosis of external ear canal

3.00

1.94

1.1

—

Spinal osteochondrosis

3.00

1.94

1.6

1.3

—

Exophthalmic conditions

2.77

1.94

1.1

1.2

—

D07AA Corticosteroids, weak (group I)

717

1.33

1.93

1.3

1.2

—

32.91

—

Hydronephrosis

429

1.43

1.93

1.1

1.2

—

35.17

—

Astigmatism

266

1.55

1.91

1.2

—

40.33

—

Single spontaneous delivery

211

1342

0.83

1.90

1.2

31.00

32.41

nmol/l

—

Disorders of phosphorus metabolism and phosphatases

3.26

1.90

1.9

1.1

—

Benign neoplasm: Brain, unspecified

3.25

1.89

1.1

—

Benign neoplasm of breast

601

1.35

1.88

1.2

—

36.25

—

Pericarditis

114

1.85

1.87

1.2

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

2.10

1.87

1.3

—

Benign neoplasm: Endocrine pancreas

3.60

1.85

1.7

1.2

—

Right bundle-branch block

122

1.81

1.84

1.0

1.3

—

Carcinoma in situ of oral cavity, oesophagus and stomach

4.24

1.83

2.0

1.2

—

Rhinophyma

4.23

1.83

1.4

1.1

—

Cicatricial alopecia [scarring hair loss]

2.62

1.81

1.2

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

411

2807

1.14

1.80

1.2

26.78

36.70

nmol/l

—

Malignant neoplasm of base of tongue

3.40

1.76

1.3

1.2

—

Infarction of spleen

3.39

1.76

1.2

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

438

1.40

1.75

1.2

—

37.83

—

Gastrojejunal ulcer

2.53

1.74

1.1

—

Ankylosing hyperostosis [Forestier]

2.53

1.74

1.2

1.3

—

Ectopic pregnancy

115

907

1.27

1.74

1.2

1.3

—

31.16

—

Mental and behavioural disorders due to opioids

147

1.71

1.74

1.3

1.2

—

25.50

—

Hallux rigidus

601

1.34

1.73

1.3

1.2

—

35.83

—

Seborrhoeic dermatitis

422

1.40

1.73

1.4

1.2

—

41.80

—

Intercostal neuropathy

2.96

1.73

1.1

1.0

—

Flatulence and related conditions

2.95

1.73

1.1

1.2

—

Malignant neoplasm of oropharynx, including Hilmo

2.15

1.72

1.2

—

Caries of enamel

661

3915

1.10

1.71

1.2

41.17

33.83

nmol/l

—

Primary biliary cholangitis, wide definition

1.93

1.70

1.2

—

Use of disulfiram, acamprosate or naltrexone

349

1.44

1.69

1.2

—

38.71

—

Benign neoplasm of other and unspecified intrathoracic organs

2.54

1.67

1.3

1.2

—

Syndrome of inappropriate secretion of antidiuretic hormone

3.22

1.67

2.3

1.1

—

Explicit fungal Sepsis

3.21

1.67

1.3

1.2

—

Explicit fungal Sepsis, including avohilmo

3.21

1.67

1.3

1.2

—

Fibrosis of liver

2.84

1.66

1.0

1.2

—

Other menopausal disorders

179

824

1.21

1.66

1.2

36.40

30.56

nmol/l

—

Pneumocystosis

2.05

1.65

1.1

1.2

—

Pneumocystosis, including avohilmo

2.05

1.65

1.1

1.2

—

Malignant neoplasm of prostate, including Hilmo

119

555

1.27

1.65

1.3

1.2

—

33.40

—

Primary biliary cholangitis (PBC)

1.95

1.65

1.4

1.2

—

Secondary uncertain malignant neoplasm

503

1.36

1.64

1.3

—

46.33

—

Varicose veins

377

2507

1.14

1.64

1.2

—

36.45

—

Female infertility, cervical, vaginal, other or unspecified origin

172

908

1.21

1.64

1.3

1.2

26.71

30.59

nmol/l

—

Ulcer of vagina/vulva

135

1.72

1.63

1.3

—

28.80

—

Other specified and unspecified disorders of choroid

3.65

1.63

1.4

1.2

—

Gastrointestinal stromal tumor and sarcoma

2.41

1.62

1.0

1.2

—

Mental disorders, not otherwise specified

394

1.40

1.62

1.0

1.2

—

30.15

—

Congenital malformations of breast

2.08

1.60

1.0

1.3

—

28.80

—

Amputation of foot

1.96

1.59

1.8

1.2

—

Carcinoma in situ of rectum

2.35

1.59

1.2

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

3.06

1.59

1.3

1.2

—

Nail dystrophy

3.05

1.59

1.2

—

Sequelae of intentional self-harm, assault and events of undetermined intent

3.04

1.59

1.2

—

Benign neoplasm: Bladder

2.72

1.58

1.0

1.1

—

Malignant neoplasm of oropharynx

2.29

1.56

1.2

—

Drug-induced hypoglycaemia without coma

2.29

1.56

1.5

1.2

—

Malignant neoplasm of larynx, including Hilmo

2.12

1.55

1.1

1.2

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

117

771

1.25

1.54

1.3

—

50.20

—

Melanocytic naevi, other sites/unspecified

381

1.40

1.54

1.2

—

39.56

—

Ulcerative rectosigmoiditis

339

1.42

1.54

1.2

—

37.86

—

Disorders of other and unspecified cranial nerves

3.39

1.53

1.4

1.1

—

Endocarditis

115

1.75

1.53

1.5

1.3

—

Unspecified renal colic

2.91

1.51

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

101

801

1.26

1.51

1.2

23.33

32.00

nmol/l

—

Cardiomyopathy, Hypertrophic obstructive

2.02

1.49

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

207

1596

1.18

1.49

1.3

1.2

—

43.83

—

Radial styloid tenosynovitis [de Quervain]

243

1.49

1.47

1.2

—

42.40

—

Other bursitis of knee

2.24

1.47

1.2

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

222

1414

1.17

1.47

1.2

—

35.25

—

Actinic keratosis

201

1557

1.18

1.46

1.3

1.2

—

43.83

—

Malignant neoplasm of vagina, including Hilmo

3.21

1.45

1.2

—

Meningitis, viral

3.18

1.45

1.4

1.3

—

Late syphilis, including avohilmo

2.05

1.44

1.3

1.1

—

Alcohol-induced acute pancreatitis

125

1.69

1.44

1.3

1.2

—

Other degenerative diseases of the nervous system

130

775

1.22

1.43

1.3

1.2

—

38.69

—

Malignant neoplasm of breast, HER-positive

221

1414

1.17

1.41

1.2

—

35.25

—

Congenital deformities of feet, including avohilmo

149

1.62

1.41

1.4

1.2

—

28.80

—

Macular pucker

667

1.28

1.40

1.2

—

44.80

—

Malignant neoplasm of respiratory system and intrathoracic organs

101

669

1.25

1.40

1.3

—

50.20

—

Aphakia

2.26

1.40

1.1

—

Pulmonary oedema

2.19

1.40

1.1

1.2

—

Recurrent and persistent haematuria

2.44

1.40

1.4

1.2

—

Liposarcoma, including Hilmo

2.44

1.40

1.3

1.2

—

Injury of unspecified body region

313

1.41

1.39

1.2

—

27.83

—

Iridocyclitis in diseases classified elsewhere

2.02

1.38

1.2

—

Sequelae of other and unspecified effects of external causes

2.65

1.37

1.3

1.2

—

Ectropion of eyelid

120

0.42

1.37

1.4

1.3

—

Pityriasis rosea

2.64

1.37

1.2

1.1

—

Hypertension, Pulmonary Arterial

2.64

1.37

1.2

—

Other necrotizing vasculopathies (FG)

190

1.53

1.37

1.0

1.3

—

Childhood allergy (age < 16)

521

1.28

1.37

1.1

1.2

29.20

26.50

nmol/l

—

Other specified/unspecified diseases of inner ear

2.99

1.36

2.4

1.3

—

Necrotizing fasciitis

2.99

1.36

1.6

1.1

—

Other specified/unspecified disorders of bone/cartilage

1.84

1.36

1.0

1.1

—

Autism spe

1.84

1.36

1.1

1.2

—

25.00

—

Aneurysms, operations, SAH

706

1.26

1.35

1.5

1.2

—

31.63

—

Anoxic brain damage

0.00

1.35

0.0

1.2

—

Malignant neoplasm of tonsil, including Hilmo

2.15

1.34

1.3

1.1

—

Malignant neoplasm of tonsil

2.16

1.34

1.2

—

Malignant neoplasm of testis, including Hilmo

2.14

1.34

1.1

1.2

—

Viral hepatitis, including avohilmo

307

1.41

1.34

1.4

1.2

—

32.67

—

Alcohol abuse counselling and surveillance

2.06

1.33

1.3

1.1

—

Malignant neoplasm of lip, including Hilmo

0.00

1.33

0.0

1.3

—

Dermatophytosis

576

1.29

1.32

1.3

1.2

—

34.11

—

Open wound of ankle and foot

428

1.34

1.31

1.3

1.2

—

32.89

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.54

1.31

1.2

—

Seminoma of testis, including Hilmo

2.52

1.31

1.2

1.1

—

Arthropathy in ulcerative colitis

2.11

1.31

1.2

1.1

—

Malignant neoplasm of testis

2.11

1.30

1.0

1.2

—

Car occupant injured in noncollision transport accident

129

1.64

1.30

1.2

1.3

—

28.80

—

Disorders of magnesium metabolism

2.39

1.30

1.0

1.2

—

Folate deficiency anaemia

2.38

1.30

1.5

1.2

—

Dislocation, sprain and strain of joints and ligaments of elbow

284

1.41

1.29

1.4

1.2

—

40.63

—

Other and unspecified disorders of orbit

2.82

1.29

1.0

1.1

—

Chromophobe cell carcinoma of kidney

2.82

1.29

1.8

1.1

—

Congenital malformations of breast, including avohilmo

1.90

1.29

1.0

1.3

—

28.80

—

Malignant neoplasm of larynx

2.10

1.28

1.1

1.2

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.02

1.24

1.2

—

Effects of air pressure and water pressure

2.67

1.22

1.0

1.1

—

Vestibular neuronitis

382

1.34

1.21

1.3

1.2

—

39.80

—

Hypermetropia

296

1.39

1.21

1.1

1.2

—

32.56

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

628

1.26

1.21

1.4

1.2

—

32.70

—

Dependence on enabling machines and devices, not elsewhere classified

2.17

1.21

1.0

1.1

—

Viral hepatitis

288

1.39

1.21

1.5

1.2

—

26.37

—

Anorexia (incl.atypical)

238

1.43

1.20

1.1

1.3

—

26.36

—

Defects in the complement system

2.34

1.19

1.5

1.2

—

Ankylosing spondylitis, ICD10

366

1.34

1.19

1.2

—

29.29

—

Primary angle-closure glaucoma

157

1.54

1.17

1.3

1.2

—

severe traumatic brain injury, does not include concussion

108

893

1.21

1.16

1.2

—

36.18

—

Isolated proteinuria with specified morphological lesion

2.07

1.16

1.1

—

Unspecified protein-energy malnutrition

2.53

1.15

1.2

—

Contact with blunt object, undetermined intent

2.53

1.15

1.0

1.1

—

Assault by blunt object

2.07

1.15

1.4

1.1

—

Autism

1.73

1.15

1.1

1.2

—

32.17

—

Any death

313

2441

0.90

1.15

1.3

1.2

—

37.83

—

Twin gestation

472

0.72

1.13

1.1

1.2

—

43.50

—

Dermatopolymyositis

1.91

1.12

1.4

1.2

—

Use of rotigotine

2.02

1.12

1.0

1.1

—

Disorders of synovium and tendon in diseases classified elsewhere

1.79

1.11

1.2

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.29

1.11

1.1

1.2

—

Atopic conjunctivitis

184

1.47

1.11

1.2

—

34.00

—

Congenital malformations of eye, ear, face and neck

268

1.39

1.10

1.2

—

32.56

—

Nontraumatic intracranial haemmorrhage

781

1.22

1.10

1.3

1.2

—

41.00

—

Disorders of speech understanding and production

125

1.57

1.09

1.1

1.2

—

27.60

—

Necrobiosis lipoidica, not elsewhere classified

2.41

1.09

1.2

—

Liposarcoma

2.41

1.09

1.4

1.2

—

Brain glioblastoma, helper endpoint

1.97

1.09

1.3

1.2

—

Malignant neoplasm of ovary, including Hilmo

292

0.65

1.09

1.3

—

47.80

—

Retinal detachments and breaks

192

1678

1.15

1.08

1.2

—

35.28

—

Malignant neoplasm of tongue, including Hilmo

1.70

1.08

1.3

1.2

—

Type 1 diabetes, definitions combined

303

1.35

1.07

1.4

1.2

—

34.15

—

Benign neoplasm: Other parts of oropharynx

2.14

1.06

1.0

1.1

—

Nail disorders

357

1.32

1.05

1.1

1.2

—

43.00

—

Amputation of ankle bones

1.80

1.05

1.6

1.2

—

Embolic stroke with flimmer

1.80

1.04

1.3

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

119

1006

1.18

1.04

1.2

—

35.20

—

Pre-eclampsia superimposed on chronic hypertension

2.30

1.04

1.4

1.2

—

Scar conditions and fibrosis of skin

187

1.45

1.04

1.3

1.2

—

28.80

—

Tarsal tunnel syndrome

2.08

1.03

1.1

—

Other specified and unspecified disorders of conjunctiva

2.08

1.03

1.1

1.2

—

Vasomotor rhinitis (mode)

324

1.33

1.02

1.3

1.2

—

37.86

—

Multiple gestation

485

0.74

1.02

1.1

1.2

—

43.50

—

Sulfasalazine

162

1407

1.15

1.02

1.2

83.60

32.04

nmol/l

—

Routine general health check-up of defined subpopulation

1.77

1.00

1.3

1.2

—

Peptic ulcer

2.02

1.00

1.3

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

627

1.23

1.00

1.2

1.3

—

37.86

—

Injury of eye and orbit

609

1.23

1.00

1.1

1.2

—

27.29

—

Adult respiratory distress syndrome

2.01

1.00

1.6

1.2

—

Motor neuron disease ALS

2.01

1.00

1.0

1.2

—

Motor neuron disease (with DMD)

2.01

1.00

1.0

1.2

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

107

1.60

1.00

1.2

—

28.80

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.62

0.99

1.2

—

28.80

—

Specific development disorders of speech and language

190

1.42

0.99

1.1

1.2

—

28.50

—

Other abnormalities of plasma proteins

1.85

0.99

1.2

1.1

—

Type 1 diabetes, strict (exclude DM2)

299

1.34

0.98

1.3

1.2

—

34.15

—

Other dermatomyositis

2.21

0.98

1.6

1.1

—

Lung transplant status

0.00

0.98

0.0

1.2

—

Lung transplantation

0.00

0.98

0.0

1.2

—

Shock, not elsewhere classified

0.00

0.98

0.0

1.2

—

Dialysis

124

1.54

0.97

1.2

—

Other specified/unspecified deforming dorsopathies

1.77

0.94

1.2

—

Neurofibromatosis, type 1

2.25

0.94

1.3

1.2

—

Accessory breast

2.25

0.94

1.0

1.3

—

Hereditary motor and sensory neuropathy

2.24

0.94

1.2

—

Other facial nerve disorders

101

1.59

0.94

1.2

1.1

—

Other juvenile arthritis

150

1.47

0.93

1.2

—

30.14

—

Pleural plaque without asbestos

118

1.53

0.91

1.2

—

L02BG Aromatase inhibitors

193

1694

1.13

0.89

1.2

—

37.58

—

Vitamin B12 deficiency anaemia

376

1.28

0.89

1.2

—

42.60

—

Other acute disseminated demyelination

1.92

0.89

1.3

1.2

—

Benign neoplasm: Spinal meninges

1.88

0.88

1.1

1.2

—

Congenital deformities of feet

1.62

0.88

1.5

1.2

—

28.80

—

Juvenile arthritis (FINNGEN)

169

1.43

0.87

1.3

1.2

—

28.67

—

Acute drug-induced interstitial lung disorder

2.02

0.87

1.0

1.2

—

Chronic suppurative otitis media, including avohilmo

298

1.31

0.87

1.3

1.2

—

35.33

—

Family history of malignant neoplasm

575

1.22

0.87

1.2

—

33.78

—

Malignant neoplasm of bone and articular cartilage

2.02

0.87

1.3

1.2

—

Eosinophilic disease (BM)

1.83

0.86

1.1

1.2

—

Other disorders of choroid

1.79

0.84

1.3

1.2

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

262

0.68

0.84

1.3

1.2

—

31.80

—

Persons encountering health services in circumstances related to reproduction

312

2285

0.91

0.84

1.2

37.25

29.18

nmol/l

—

Medicines for HER+ breast cancer

237

1996

1.11

0.82

1.2

—

35.52

—

Polymyositis

1.89

0.82

1.2

—

Late syphilis

1.71

0.81

1.5

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

130

1.47

0.81

1.2

—

28.17

—

Valvular operations

454

1.24

0.80

1.3

—

30.00

—

Heart failure and hypertrophic cardiomyopathy

1.73

0.80

2.1

1.2

—

Ankylosing spondylitis, strict definition

164

1.41

0.80

1.3

1.2

—

34.00

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

0.79

0.0

1.2

—

Hypotension due to drugs

1.68

0.79

1.5

1.2

—

Multifocal fibrosclerosis

0.00

0.78

0.0

1.2

—

Malignant neoplasm of lip

0.00

0.78

0.0

1.3

—

Generalized epilepsy

165

1.40

0.77

1.2

—

30.33

—

Chronic myeloid leukaemia, including Hilmo

1.78

0.76

1.0

1.1

—

Disorders of brain, other and unspecified

1.78

0.76

1.2

1.1

—

Contact with lifting and transmission devices, not elsewhere classified

1.71

0.76

1.3

1.2

—

Acute nephritic syndrome

1.70

0.76

1.1

—

Other disorders of male genital organs

1.52

0.75

1.1

1.2

—

Hypoplasia of dental enamel , including avohilmo

111

1.48

0.75

1.5

1.2

—

33.00

—

Drug-induced tremor

2.10

0.75

1.2

—

Exposure to other and unspecified inanimate mechanical forces

315

1.27

0.74

1.4

1.2

—

37.83

—

Other and unspecified bullous disorders

1.86

0.74

1.3

1.2

—

Exfoliative dermatitis

1.86

0.74

1.3

1.2

—

Other immunodeficiencies

1.86

0.74

1.4

1.2

—

L02BA Anti-estrogens

895

0.85

0.73

1.2

—

35.00

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

169

1.33

0.73

1.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

2.02

0.73

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.02

0.73

1.0

1.2

—

Premature separation of placenta [abruptio placentae]

107

0.56

0.72

1.8

1.2

—

39.75

—

Neuroendocrine tumor and carcinoma of small intestine

1.68

0.72

1.4

1.2

—

Acquired absence of organs, not elsewhere classified

1.76

0.71

1.0

1.2

—

Other disorders starting during childhood or adolescence

193

1.34

0.69

1.1

—

27.91

—

Melanoma in situ of upper limb, including shoulder

1.87

0.68

1.4

1.3

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

1.87

0.68

1.4

1.1

—

Ulcerative proctitis

248

1.29

0.68

1.3

1.2

—

30.33

—

Use of antiglaucoma preparations and miotics

275

1.28

0.68

1.3

1.2

—

Other viral hepatitis

240

1.30

0.67

1.5

1.2

—

27.43

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

262

1670

0.92

0.67

1.3

1.2

19.86

35.58

nmol/l

—

Other viral hepatitis, including avohilmo

258

1.28

0.67

1.5

1.2

—

26.38

—

Migraine, unspecified, drug-induced

1.80

0.66

1.0

1.2

—

Malignant neoplasm of tongue

1.58

0.65

1.5

1.2

—

Atypical mycobacterium lung infection

1.60

0.65

1.3

1.1

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

1.58

0.65

1.4

1.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.60

0.65

1.3

1.2

—

Dislocation of lens

1.60

0.65

1.3

1.2

—

Contact with machinery

385

1.22

0.65

1.2

1.3

—

33.00

—

Cystic disease of liver

1.74

0.64

1.2

1.1

—

Complications of labour and delivery

389

2308

0.94

0.63

1.2

36.55

37.76

nmol/l

0.04

Bacterial, viral and other infectious agents

348

0.77

0.63

1.4

1.2

—

26.57

—

Cysts of oral region, not elsewhere classified

234

1.29

0.63

1.5

1.2

—

28.80

—

Other congenital malformations of face and neck

104

1.45

0.62

1.2

—

28.80

—

Type 1 diabetes, strict definition

234

1.28

0.61

1.4

1.2

—

28.82

—

Calcific tendinitis

1.68

0.61

1.2

—

Spinal enthesopathy

1.57

0.60

1.1

1.2

—

Other contact dermatitis

353

1.22

0.60

1.5

1.2

—

37.14

—

Other disorders of prostate

1.50

0.60

1.3

1.2

—

Cerebral amyloid angiopathy

0.00

0.59

0.0

1.2

—

Toxic effect of contact with venomous animals

166

1.33

0.58

1.2

—

28.80

—

Polyarteritis nodosa

0.00

0.58

0.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

304

1.23

0.57

1.2

—

30.69

—

Dissocial personality disorder

1.49

0.57

1.1

1.2

—

Toxic effects of substances chiefly nonmedicinal as to source

493

1.18

0.57

1.2

—

33.40

—

Malignant neoplasm of base of tongue, including Hilmo

1.68

0.57

1.3

1.2

—

Antepartum haemorrhage, not elsewhere classified

452

0.82

0.57

1.2

—

44.20

—

Exposure to unspecified smoke, fire and flames

1.68

0.57

1.3

1.2

—

Infection due to other mycobacteria

1.46

0.56

1.3

1.1

—

Type 1 diabetes, strict definition, subgroup 1

220

1.27

0.56

1.3

1.2

—

28.82

—

Hepatocellular carcinoma

1.54

0.55

1.1

1.2

—

Pedestrian injured in transport accident

284

1.24

0.55

1.2

—

28.80

—

Convergent concomitant strabismus

230

1.26

0.55

1.3

1.2

—

30.86

—

Noise effects on inner ear

122

0.65

0.54

1.1

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

253

1585

1.08

0.54

1.2

—

36.17

—

Other demyelinating diseases of the central nervous system

160

1.32

0.53

1.4

1.2

—

27.83

—

Pulmonary eosinophilia, not elsewhere classified

1.55

0.53

1.2

—

Diabetic retinopathy, strict definition

132

1060

1.11

0.53

1.1

1.3

—

24.29

—

Seronegative rheumatoid arthritis

479

1.17

0.52

1.3

—

30.20

—

Other assisted single delivery

0.61

0.52

1.2

—

31.57

—

Procreative management

200

1520

1.08

0.52

1.2

31.43

26.35

nmol/l

—

Haemorrhagic disorder due to circulating anticoagulants

1.51

0.51

1.3

1.2

—

Torsion of testis

1.47

0.50

1.3

1.2

—

Alzheimer’s disease (Early onset), excluding more controls

1.46

0.49

1.3

—

Glaucoma secondary to other eye disorders

145

1.31

0.49

1.2

—

Horner syndrome

1.53

0.48

1.1

1.2

—

Molar incisor enamel hypoplasia

122

1.33

0.48

1.5

1.2

—

33.75

—

Tularaemia

1.50

0.47

1.1

1.2

—

Other puerperal infections

401

1.17

0.47

1.2

—

32.94

—

Basal cell carcinoma, including Hilmo

241

1526

1.07

0.45

1.2

—

36.71

—

Crystal arthropathies, rheuma endpoint

1.40

0.45

1.0

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

238

1512

1.07

0.44

1.2

—

36.71

—

Foreign body or object entering through skin

238

1.22

0.44

1.1

1.2

—

28.80

—

Maternal care for cervical incompetence

202

1.24

0.43

1.3

1.2

—

28.80

—

Basal cell carcinoma

231

1474

1.07

0.43

1.2

1.3

—

36.71

—

Other nutritional anaemias

1.62

0.43

1.0

1.2

—

Other forms of systemic lupus erythematosus

1.57

0.42

1.0

1.3

—

Other osteochondropathies

276

1.20

0.42

1.1

1.2

—

36.00

—

Biliary cirrhosis, NAS

0.00

0.41

0.0

1.1

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

0.41

0.0

1.3

—

Autoimmune hepatitis

1.52

0.41

1.4

1.2

—

Melanoma of uvea

1.52

0.41

1.0

1.1

—

Congenital hydrocephalus

0.00

0.41

0.0

1.3

—

Adult-onset Still disease

0.00

0.41

0.0

1.3

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

0.00

0.41

0.0

1.3

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.41

0.0

1.2

—

Alcoholic cardiomyopathy

0.00

0.41

0.0

1.1

—

Lichen planus

595

1.13

0.41

1.3

—

37.83

—

Injury of blood vessels at hip and thigh level

0.00

0.41

0.0

1.2

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.41

0.0

1.1

—

Status post-ami

104

717

1.10

0.41

1.3

—

36.67

—

Hypersensitivity angiitis

0.00

0.41

0.0

1.2

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.41

0.0

1.1

—

Use of entacapone

0.00

0.41

0.0

1.1

—

Malignant neoplasm of ureter, including Hilmo

1.48

0.40

1.2

—

Mental and behavioural disorders due to hallucinogens

0.00

0.40

0.0

1.2

—

Cleft lip and palate

0.00

0.40

0.0

1.2

—

Other corneal oedema

1.44

0.39

1.0

1.2

—

Benign neoplasm: Scapula and long bones of upper limb

1.43

0.39

1.2

—

Arteriovenous malformation of cerebral vessels

1.43

0.39

1.2

—

Generalized epilepsy, strict definition

1.41

0.39

1.3

1.2

—

28.80

—

Amoebiasis

0.00

0.39

0.0

1.3

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.39

0.0

1.2

—

Schizoaffective disorder

325

1.17

0.39

1.2

—

33.30

—

Open bite

226

0.79

0.39

1.0

1.2

—

34.08

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.37

0.38

1.0

1.2

—

Trichomoniasis, including avohilmo

1.39

0.38

1.2

—

Bacterial, viral and other infectious agents, including avohilmo

377

0.85

0.38

1.4

1.2

—

26.38

—

Myeloid leukaemia

1.35

0.38

1.0

1.1

—

Varicella [chickenpox], including avohilmo

179

1.23

0.37

1.3

1.2

—

26.33

—

Other surgical follow-up care

134

1.27

0.37

1.4

1.2

—

28.80

—

Other/unspecified rheumatoid arthritis

535

0.88

0.36

1.2

—

39.67

—

Cerebral atherosclerosis

1.46

0.36

1.5

1.2

—

Hordeolum and other deep inflammation of eyelid

254

1.18

0.35

1.2

—

35.17

—

Melanoma in situ of other and unspecified parts of face

1.37

0.34

1.2

—

Vascular dementia

256

0.83

0.34

1.5

1.2

—

Carcinoma in situ of skin of ear and external auricular canal

1.34

0.34

1.0

1.2

—

Aortic valve malfunction, age under 60 years

360

1.14

0.32

1.4

1.2

—

44.00

—

Other and unspecified mononeuropathies of lower limb

101

1.29

0.31

1.3

1.2

—

Melanoma in situ of trunk

1.35

0.31

1.0

1.1

—

Carcinoma in situ of skin, other sites/unspecified

1.32

0.31

1.7

1.2

—

Disorders of iron metabolism

1.32

0.31

1.0

1.2

—

Non-small cell lung cancer, squamous, helper endpoint

142

0.77

0.30

1.3

1.2

—

Tooth eruption problems

650

0.91

0.30

1.2

—

29.55

—

Other bursal cyst

1.30

0.30

1.0

1.1

—

Chronic suppurative otitis media

249

1.17

0.30

1.3

1.2

—

43.00

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

296

1.15

0.30

1.3

1.2

—

35.12

—

Tooth agenesis EXCLUDE clefts and syndromes

147

1.22

0.30

1.1

1.2

—

33.75

—

Congenital malformations of heart and great arteries

519

0.90

0.29

1.5

1.2

—

33.79

—

Carcinoma in situ of cervix uteri

535

0.90

0.29

1.2

—

36.67

—

Nasal polyp

785

1.08

0.28

1.2

—

29.55

—

Maternal care for known or suspected disproportion

216

0.83

0.28

1.2

—

41.00

—

Pemphigoid

1.28

0.28

1.2

—

Other obstetric trauma

269

0.85

0.27

1.0

1.2

—

35.45

—

Seborrhoeic keratosis

117

1247

0.94

0.27

1.3

1.2

—

33.50

—

Other bursitis of hip

1.30

0.26

1.5

1.1

—

Amyloidosis

0.69

0.26

1.2

1.1

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.68

0.26

1.0

1.2

—

Alzheimer disease, excluding more controls

391

1.09

0.26

1.2

1.3

—

Bullous pemphigoid

1.25

0.25

1.2

—

Cytomegalovirus infection, IBD co-morbidity

1.24

0.25

1.4

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

123

1208

0.94

0.25

1.2

28.80

38.37

nmol/l

—

Small cell lung cancer, including Hilmo

1.19

0.24

1.1

1.2

—

Small cell lung cancer

1.19

0.24

1.1

1.2

—

Lyme disease, including avohilmo

174

1825

0.95

0.24

1.3

1.2

41.40

30.93

nmol/l

—

Lyme disease

174

1825

0.95

0.24

1.3

1.2

41.40

30.93

nmol/l

—

Stenosis and insufficiency of lacrimal passages

413

0.89

0.24

1.2

—

35.57

—

Acute lymphadenitis

236

1.15

0.24

1.4

1.2

—

29.57

—

Amputation of thigh

0.73

0.24

1.2

—

Other spirochaetal diseases

176

1842

0.96

0.23

1.3

1.2

41.40

30.93

nmol/l

—

Personal history of malignant neoplasm

401

0.90

0.23

1.2

1.3

—

36.00

—

Other and unspecified mononeuropathies, also in other diseases

1.24

0.23

1.1

—

Carcinoma in situ of skin of scalp and neck

0.77

0.22

1.0

1.2

—

Optic neuritis

181

1.16

0.22

1.6

1.2

—

31.83

—

Failure and rejection of transplanted organs and tissues

1.25

0.22

1.2

1.1

—

Congenital malformations of the circulatory system

600

0.92

0.22

1.3

1.2

—

32.25

—

Mature T/NK-cell lymphomas, hilmo

1.22

0.22

1.0

1.1

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

1.1

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.3

—

Drug-induced aplastic anaemia

0.00

0.21

0.0

1.1

—

Lipodystrophy, not elsewhere classified

0.00

0.21

0.0

1.2

—

Other spirochaetal diseases, including avohilmo

180

1878

0.96

0.21

1.3

1.2

41.40

30.93

nmol/l

—

Acrodermatitis chronica atrophicans

0.00

0.21

0.0

1.3

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.2

—

Haemophilus septicemia

0.00

0.21

0.0

1.0

—

Telogen effluvium

0.00

0.21

0.0

1.4

—

Other infestations

0.00

0.21

0.0

1.3

—

Congenital malformations of nose, including avohilmo

0.00

0.21

0.0

1.3

—

Diseases of thymus

0.00

0.21

0.0

1.3

—

Acne varioliformis

0.00

0.21

0.0

1.0

—

Eclampsia

0.00

0.21

0.0

1.3

—

Multiple congenital exostoses, including avohilmo

0.00

0.21

0.0

1.1

—

Secondary systemic amyloidosis

0.00

0.21

0.0

1.2

—

Other and unspecified heterotropia

0.00

0.21

0.0

1.4

—

Frostbite with tissue necrosis

0.00

0.21

0.0

1.2

—

Unspecified multiple injuries

0.00

0.21

0.0

1.2

—

Other cestode infections

0.00

0.21

0.0

1.1

—

Oher contracture of tendon (sheath)

0.00

0.21

0.0

1.2

—

Internuclear ophthalmoplegia

0.00

0.21

0.0

1.2

—

Other cestode infections, including avohilmo

0.00

0.21

0.0

1.1

—

Unspecified organic or symptomatic mental disorder

0.00

0.21

0.0

1.1

—

Nezelof syndrome

0.00

0.21

0.0

1.3

—

Atrioventricular septal defect

0.00

0.21

0.0

1.3

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.1

—

Other operation for atrial fibrillation

0.00

0.21

0.0

1.1

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.1

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

0.21

0.0

1.1

—

Toxic effect of corrosive substances

0.00

0.21

0.0

1.1

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.2

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.3

—

Abnormalities of ear ossicles

0.00

0.21

0.0

1.2

—

Erythema in diseases classified elsewhere

0.00

0.21

0.0

1.3

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.3

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.1

—

Other congenital malformations of integument, including avohilmo

0.00

0.21

0.0

1.2

—

Explosion of other materials

0.00

0.21

0.0

1.2

—

Injury of blood vessels at forearm level

0.00

0.21

0.0

1.1

—

Down's syndrome

0.00

0.21

0.0

1.3

—

Lupus nephritis

0.00

0.21

0.0

1.3

—

Other and unspecified syphilis, including avohilmo

0.00

0.21

0.0

1.2

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.21

0.0

1.1

—

Other disorders of amino-acid metabolism

0.00

0.21

0.0

1.2

—

Listeriosis

0.00

0.21

0.0

1.1

—

Measles

1.16

0.21

1.2

—

Measles, including avohilmo

1.16

0.21

1.2

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

1.2

—

Esophageal diverticulum (pouch), including avohilmo

0.00

0.21

0.0

1.2

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

0.21

0.0

1.1

—

Hypersplenism

0.00

0.21

0.0

1.2

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.2

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.2

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.21

0.0

1.2

—

Bilateral sagittal split ramus osteotomy operation

145

1.17

0.20

1.1

1.2

—

30.33

—

False labour

188

1119

1.04

0.20

1.3

1.2

22.13

33.67

nmol/l

—

Supervision of high-risk pregnancy

117

741

0.95

0.20

1.2

16.60

28.74

nmol/l

—

Dengue fever [classical dengue], including avohilmo

0.00

0.20

0.0

1.2

—

Other congenital malformations of skin, including avohilmo

364

1.10

0.20

1.1

1.2

—

31.73

—

Pediculosis and phthiriasis

0.00

0.20

0.0

1.2

—

Restrictive cardiomyopathy

0.00

0.20

0.0

1.3

—

Other and unspecified water transport accidents

0.00

0.20

0.0

1.2

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.20

0.0

1.3

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.20

0.0

1.1

—

Colour vision deficiencies

0.00

0.20

0.0

1.1

—

Use of levodopa decarbox-comt-inhibitor

115

0.78

0.20

1.1

—

Nonspecific lymphadenitis

260

0.88

0.19

1.3

1.2

—

36.00

—

Other arterial embolism and thrombosis

1.22

0.19

1.4

1.2

—

Inguinal hernia

274

1878

0.97

0.19

1.2

29.25

28.08

nmol/l

—

Schizophrenia

695

1.07

0.19

1.2

—

29.70

—

Anaemia in chronic diseases classified elsewhere

1.24

0.19

1.1

1.2

—

Lesion of radial nerve

128

1.17

0.18

1.2

—

Lesion of sciatic nerve

128

1.17

0.18

1.1

1.2

—

Other (seronegative) rheumatoid arthritis, wide

908

0.95

0.18

1.3

1.2

—

31.38

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

377

1.09

0.17

1.4

1.2

—

37.86

—

Myelodysplastic syndrome, including Hilmo

1.21

0.17

1.0

1.3

—

Certain zoonotic bacterial diseases

1.15

0.17

1.1

1.2

—

Human immunodeficiency virus [HIV] disease

1.13

0.17

1.0

1.1

—

Tuberculosis of other organs

1.11

0.17

1.3

1.1

—

Embedded teeth, including avohilmo

413

0.92

0.17

1.3

1.2

—

31.56

—

Congenital malformations of uterus and cervix

101

1.19

0.16

1.0

1.3

—

28.80

—

Contraceptive management

253

1717

1.03

0.16

1.2

37.71

30.63

nmol/l

—

Distal bite

119

1.17

0.16

1.4

1.2

—

31.88

—

Chronic viral hepatitis

196

1.12

0.16

1.7

1.2

—

28.80

—

Spirochaetal infections, other/unspecified, including avohilmo

178

1841

0.97

0.16

1.3

1.2

41.40

30.93

nmol/l

—

LSIL lesion of the cervix uteri

627

0.94

0.15

1.3

1.2

—

35.17

—

Small cell lung cancer, helper endpoint

1.13

0.15

1.1

1.2

—

Melanocytic naevi of other and unspecified parts of face

265

1.10

0.14

1.2

—

37.83

—

Other and unspecified degenerative diseases of nervous system

1.18

0.14

1.5

1.2

—

Other superficial mycoses, including avohilmo

500

1.06

0.13

1.3

1.2

—

32.71

—

Other appendicitis

354

1.07

0.13

1.1

1.2

—

33.89

—

Foreign body entering into or through eye or natural orifice

293

0.92

0.12

1.1

1.2

—

28.80

—

Coronary artery bypass grafting

671

0.96

0.11

1.3

—

36.67

—

Other specified/unspecified systemic involvement of connective tissue

269

1.08

0.11

1.2

—

37.86

—

Obstructed labour due to maternal pelvic abnormality

822

0.96

0.11

1.2

—

33.00

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

338

1.07

0.10

1.2

—

39.33

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

398

1.06

0.10

1.4

1.2

—

35.50

—

Deep bite that required surgery

1.06

0.09

1.0

1.2

—

Other benign neoplasm of uterus: Other parts/unspecified

145

0.90

0.09

1.0

1.2

—

Congenital malformations of cardiac septa

240

0.93

0.09

1.4

1.2

—

28.86

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.04

0.09

1.4

1.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

328

2375

1.02

0.09

1.2

27.71

36.33

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.11

0.09

1.2

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

1.11

0.09

1.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

1.11

0.09

1.0

1.1

—

1.07

0.08

1.0

1.2

—

38.33

—

Foreign body in respiratory tract

204

1.08

0.08

1.1

1.2

—

33.60

—

Alzheimer’s disease (Late onset), excluding more controls

333

0.96

0.08

1.3

—

MS-disease / Multiple Sclerosis

341

1.06

0.08

1.4

1.2

—

34.29

—

Benign neoplasm of male genital organs

1.05

0.08

1.2

1.1

—

Schizoid personality disorder

1.03

0.08

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

312

1.06

0.08

1.2

—

30.33

—

Other and unspecified hydrocephalus

0.83

0.08

1.2

—

Vertigo of central origin

0.80

0.08

1.2

1.1

—

Human immunodeficiency virus [HIV] disease, including avohilmo

1.09

0.08

1.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

114

1169

0.97

0.08

1.3

1.2

—

32.12

—

Demyelinating diseases of the central nervous system

401

1.05

0.08

1.4

1.2

—

33.53

—

Use of galantamine

246

0.93

0.08

1.5

1.3

—

Tuberculosis of other organs, strict

1.05

0.08

1.3

1.2

—

Tuberculosis of other organs, strict, including avohilmo

1.05

0.08

1.3

1.2

—

Other infestations, including avohilmo

0.84

0.07

2.5

1.1

—

Carcinoma in situ of skin of lower limb, including hip

1.07

0.07

1.6

1.2

—

Exposure to other specified electric current

0.82

0.07

1.0

1.2

—

28.80

—

Epiphora

1.05

0.07

1.1

1.2

—

Infective bursitis

0.87

0.06

1.4

1.2

—

Vascular dementia (undefined)

0.84

0.06

1.6

1.3

—

Mental retardation, wide definition

118

1.09

0.06

1.2

—

28.80

—

Other inflammation of vagina/vulva

188

1.06

0.05

1.2

—

34.89

—

Non-small cell lung cancer, squamous

120

0.92

0.05

1.3

1.2

—

Inflammatory disorders of breast

337

1.04

0.05

1.3

1.2

—

32.86

—

Erectile dysfunction

211

0.95

0.04

1.2

1.3

—

Alzheimer’s disease (Atypical or mixed)

328

0.96

0.04

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

1.10

0.04

1.2

—

Rash and other nonspecific skin eruption

423

0.97

0.04

1.3

1.2

—

39.80

—

Thrombocytopenia, unspecified

281

1.03

0.02

1.1

1.2

—

28.80

—

Certain conditions originating in the perinatal period

283

0.97

0.02

1.1

1.2

—

31.83

—

Benign mammary dysplasia

730

0.99

0.02

1.2

—

35.85

—

Retinal breaks without detachment

750

0.99

0.02

1.2

—

41.11

—

Pedal cyclist injured in noncollision transport accidents

511

1.02

0.02

1.2

—

35.00

—

Single delivery by caesarean section

120

691

0.99

0.02

1.1

1.2

20.60

29.00

nmol/l

—

Progressive vascular leukoencephalopathy

123

1.06

0.01

1.2

1.3

—

Septal defects

222

0.97

0.01

1.5

1.2

—

28.86

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.06

0.01

1.3

—

28.80

—

Pedal cyclist injured in collision with motor vehicle

116

0.95

0.00

1.2

—

28.80

—

Maternal care for other known or suspected fetal problems

147

926

1.00

0.00

1.2

29.00

33.67

nmol/l

—

Lichen planus, including avohilmo

957

1.00

0.00

1.3

1.2

—

31.83

—

Complications of the puerperium, not elsewhere classified

195

0.97

0.00

1.2

—

27.00

—

Unspecified abortion

225

0.98

0.00

1.0

1.2

—

21.71

—

Acute bronchiolitis

173

0.99

0.00

1.1

—

29.90

—

Polyhydramnios

234

0.98

0.00

1.3

1.2

—

45.36

—

L02BX Other hormone antagonists and related agents

168

1.01

0.00

1.4

1.2

—

Suggestive for eosinophilic asthma

366

1.01

0.00

1.2

—

43.67

—

LeFortI or BSSO operation

178

1.01

0.00

1.1

1.2

—

37.86

—

Type1 diabetes, definitions combined, early onset

242

0.99

0.00

1.5

1.2

—

25.92

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

145

0.97

0.00

1.2

1.3

—

28.80

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.4

—

Congenital myopathies

0.00

0.0

1.1

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.3

—

Congenital heart conduction disorder

0.00

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs

0.95

0.00

1.3

1.2

—

Hypospadias

0.00

0.0

1.0

—

Melanoma in situ of eyelid, including canthus

0.00

0.0

1.2

—

Congenital lactase deficiency

0.00

0.0

1.1

—

Other congenital malformations of integument

0.00

0.0

1.0

—

Traumatic amputation of part of head

0.00

0.0

1.0

—

Glanders and melioidosis, including avohilmo

0.00

0.0

1.3

—

Glanders and melioidosis

0.00

0.0

1.3

—

Other congenital malformations of spinal cord

0.00

0.0

1.1

—

Other and unspecified syphilis

0.00

0.0

1.1

—

Leishmaniasis, including avohilmo

0.00

0.0

1.4

—

Transient retinal artery occlusion

0.00

0.0

1.2

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.3

—

Autoimmune polyglandular failure

0.00

0.0

1.0

—

Other nonautoimmune haemolytic anaemias

0.00

0.0

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.0

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.3

—

Disorders of fatty-acid metabolism

0.00

0.0

1.6

—

Drug-induced fever

0.00

0.0

1.4

—

Haemolytic-uraemic syndrome

0.00

0.0

1.1

—

Oesophagitis, drug-induced

0.00

0.0

1.0

—

Sequelae of hyperalimentation

0.00

0.0

1.3

—

Cardiomyopathy due to drugs and other external agents

0.00

0.0

1.3

—

Absence of one kidney, including avohilmo

0.00

0.0

1.0

—

Hypothermia

0.98

0.00

1.0

1.1

—

Poikiloderma of Civatte

0.00

0.0

1.3

—

Congenital dyserythropoietic anaemia

0.00

0.0

1.0

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.5

—

Congenital malformations of great veins

0.00

0.0

1.2

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Mental and behavioural disorders due to cannabinoids

0.97

0.00

1.7

1.2

—

24.40

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.1

—

Abscess of mediastinum

0.00

-0.00

0.0

1.3

—

Other conditions related to polyarteritis nodosa

0.00

-0.00

0.0

1.2

—

Enterohaemorrhagic Escherichia coli infection

0.00

-0.00

0.0

1.4

—

Mental and behavioural disorders due to cocaine

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.4

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.2

—

Thyroid crisis or storm

0.00

-0.00

0.0

1.2

—

Acquired coagulation factor deficiency

0.00

-0.00

0.0

1.3

—

Sequelae of malnutrition and other nutritional deficiencies

0.00

-0.00

0.0

1.2

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.98

-0.00

1.2

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.5

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

1.2

—

Congenital and developmental myasthenia

0.00

-0.00

0.0

1.0

—

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.6

—

Protrusioacetabuli

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of meninges

0.00

-0.00

0.0

1.0

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.2

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.2

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.2

—

Congenital malformations of nose

0.00

-0.00

0.0

1.1

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

Melanoma in situ, other sites/unspecified

0.00

-0.00

0.0

1.1

—

Victim of lightning

0.00

-0.00

0.0

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.2

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.1

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.1

—

Unspecified drowning and submersion

0.00

-0.00

0.0

1.2

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.4

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.2

—

Vascular dementia (subcortical)

0.93

-0.00

1.6

1.2

—

Ophthalmic devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.2

—

Intentional self-harm by crashing of motor vehicle

0.00

-0.00

0.0

1.2

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.2

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.2

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

-0.00

0.0

1.2

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

1.0

—

Exposure to sunlight

0.00

-0.00

0.0

1.2

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.2

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

1.4

—

Other effects of reduced temperature

0.00

-0.00

0.0

1.3

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Fracture of spine, level unspecified

0.00

-0.00

0.0

1.3

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.1

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.0

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

1.1

—

Reduction defects of unspecified limb, including avohilmo

0.00

-0.00

0.0

1.0

—

Syndactyly

0.00

-0.00

0.0

1.0

—

Follicular keratosis (Darier-White), including avohilmo

0.00

-0.00

0.0

1.2

—

Reduction defects of upper limb

0.00

-0.00

0.0

1.1

—

Spina bifida

0.00

-0.00

0.0

1.3

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.1

—

Congenital malformations of lung

0.00

-0.00

0.0

1.3

—

Congenital malformations of lung, including avohilmo

0.00

-0.00

0.0

1.3

—

Aortic stenosis

0.00

-0.00

0.0

1.2

—

Supernumerary ureter

0.00

-0.00

0.0

1.3

—

Reduction defects of upper limb, including avohilmo

0.00

-0.00

0.0

1.1

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

1.2

—

Cleft lip

0.00

-0.00

0.0

1.4

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

Ectopic testis

0.00

-0.00

0.0

1.1

—

Alport

0.00

-0.00

0.0

1.2

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.2

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

1.0

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.0

—

Sweet's syndrome

0.00

-0.00

0.0

1.3

—

Pemphigus erythematosus

0.00

-0.00

0.0

1.2

—

Pneumoconiosis due to other inorganic dusts

0.00

-0.00

0.0

1.2

—

Calcium deposit in bursa

0.00

-0.00

0.0

1.1

—

Macular pucker, drug-induced

0.00

-0.00

0.0

1.1

—

Pemphigus foliaceus

0.00

-0.00

0.0

1.2

—

Unspecified hairloss

0.00

-0.00

0.0

1.3

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.3

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.3

—

Pityriasis lichenoides et varioliformis acuta

0.00

-0.00

0.0

1.2

—

Toxic erythema

0.00

-0.00

0.0

1.2

—

Febrile neutrophilic dermatosis [Sweet]

0.00

-0.00

0.0

1.3

—

Overjet

0.95

-0.00

1.3

1.2

—

30.20

—

Lichen nitidus

0.00

-0.00

0.0

1.2

—

Scissor bite

0.98

-0.00

1.0

1.1

—

30.20

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Rheumatoid lung disease

0.00

-0.00

0.0

1.1

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.0

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of trunk

120

1.00

-0.00

1.3

1.2

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.3

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

-0.00

0.0

1.1

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.1

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.4

—

Malignant otitis externa

0.00

-0.00

0.0

1.3

—

Blindness (ICD-9)

0.00

-0.00

0.0

1.2

—

Idiopathic progressive neuropathy

0.00

-0.00

0.0

1.3

—

Other lesions of median nerve

0.98

-0.00

1.0

1.2

—

Hypotony of eye

0.00

-0.00

0.0

1.0

—

Absence of one kidney

0.00

-0.00

0.0

1.0

—

Disorders of optic chiasm

0.00

-0.00

0.0

1.0

—

Hereditary spastic paraplegia

0.00

-0.00

0.0

1.3

—

Other cranial nerve disorders in other disorders

0.00

-0.00

0.0

1.0

—

Disease of thymus, other/unspecified

0.00

-0.00

0.0

1.4

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.2

—

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

-0.00

0.0

1.0

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.3

—

Non-neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

1.6

—

Qualitative platelet defects

0.00

-0.00

0.0

1.2

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

-0.00

0.0

1.4

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.2

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.2

—

Amyloidosis, other/unspecified

0.85

-0.00

1.2

—

Defects in post-translational modification of lysosomal enzymes

0.00

-0.00

0.0

1.2

—

Other and unspecified thalassaemias

0.00

-0.00

0.0

1.5

—

Selective deficiency of immunoglobulin M [IgM]

0.00

-0.00

0.0

1.4

—

Immunodeficiency with short-limbed stature

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.2

—

Cyst of spleen

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of tongue

0.93

-0.00

1.6

1.1

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.1

—

Ependymoma

0.00

-0.00

0.0

1.2

—

Leishmaniasis

0.00

-0.00

0.0

1.4

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.1

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.1

—

Nocardiosis, including avohilmo

0.00

-0.00

0.0

1.2

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.0

—

Nocardiosis

0.00

-0.00

0.0

1.2

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.2

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS